[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6344 Received in Senate (RDS)]


109th CONGRESS
  2d Session
                                H. R. 6344


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            December 7, 2006

                                Received

_______________________________________________________________________

                                 AN ACT


 
     To reauthorize the Office of National Drug Control Policy Act.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE, REFERENCE, AND TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Office of National 
Drug Control Policy Reauthorization Act of 2006''.
    (b) Amendment of Office of National Drug Control Policy 
Reauthorization Act of 1998.--Except as otherwise expressly provided, 
whenever in this Act an amendment or repeal is expressed in terms of an 
amendment to, or repeal of, a section or other provision, the reference 
shall be considered to be made to a section or other provision of the 
Office of National Drug Control Policy Reauthorization Act of 1998 
(Public Law 105-277; 21 U.S.C. 1701 et seq.).
    (c) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title, reference, and table of contents.
  TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND 
                       ROLES AND RESPONSIBILITIES

Sec. 101. Amendments to definitions.
Sec. 102. Establishment of the Office of National Drug Control Policy.
Sec. 103. Appointment and responsibilities of the Director.
Sec. 104. Amendments to ensure coordination with other agencies.
Sec. 105. Budgetary matters.
              TITLE II--THE NATIONAL DRUG CONTROL STRATEGY

Sec. 201. Annual preparation and submission of National Drug Control 
                            Strategy.
Sec. 202. Performance measurements.
Sec. 203. Annual report requirement.
            TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS

Sec. 301. High Intensity Drug Trafficking Areas Program.
Sec. 302. Funding for certain high intensity drug trafficking areas.
Sec. 303. Assessment.
                          TITLE IV--TECHNOLOGY

Sec. 401. Counterdrug Technology Assessment Center.
                 TITLE V--NATIONAL YOUTH MEDIA CAMPAIGN

Sec. 501. National Youth Anti-Drug Media Campaign.
       TITLE VI--AUTHORIZATIONS AND EXTENSION OF TERMINATION DATE

Sec. 601. Authorization of appropriations.
Sec. 602. Extension of termination date.
                     TITLE VII--ANTI-DOPING AGENCY

Sec. 701. Designation of United States Anti-Doping Agency.
Sec. 702. Records, audit, and report.
Sec. 703. Authorization of appropriations.
                   TITLE VIII--DRUG-FREE COMMUNITIES

Sec. 801. Reauthorization.
Sec. 802. Suspension of grants.
Sec. 803. Grant award increase.
Sec. 804. Prohibition on additional eligibility criteria.
Sec. 805. National Community Anti-Drug Coalition Institute.
              TITLE IX--NATIONAL GUARD COUNTERDRUG SCHOOLS

Sec. 901. National Guard counterdrug schools.
TITLE X--NATIONAL METHAMPHETAMINE INFORMATION CLEARINGHOUSE ACT OF 2006

Sec. 1001. Short title.
Sec. 1002. Definitions.
Sec. 1003. Establishment of clearinghouse and advisory council.
Sec. 1004. NMIC requirements and review.
Sec. 1005. Authorization of appropriations.
                   TITLE XI--MISCELLANEOUS PROVISIONS

Sec. 1101. Repeals.
Sec. 1102. Controlled Substances Act amendments.
Sec. 1103. Report on law enforcement intelligence sharing.
Sec. 1104. Requirement for South American heroin strategy.
Sec. 1105. Model acts.
Sec. 1106. Study on iatrogenic addiction associated with prescription 
                            opioid analgesic drugs.
Sec. 1107. Requirement for strategy to stop Internet advertising of 
                            prescription medicines without a 
                            prescription.
Sec. 1108. Requirement for study on diversion and inappropriate uses of 
                            prescription drugs.
Sec. 1109. Requirement for Afghan Heroin Strategy.
Sec. 1110. Requirement for Southwest Border Counternarcotics Strategy.
Sec. 1111. Requirement for Scientific Study of Mycoherbicide in Illicit 
                            Drug Crop Eradication.
Sec. 1112. Requirement for Study of State Precursor Chemical Control 
                            Laws.
Sec. 1113. Requirement for Study of Drug Endangered Children Programs.
Sec. 1114. Study on drug court hearings in nontraditional places.
Sec. 1115. Report on tribal Government participation in HIDTA process.
Sec. 1116. Report on school drug testing.
Sec. 1117. Report on ONDCP performance bonuses.
Sec. 1118. Requirement for disclosure of Federal sponsorship of all 
                            Federal advertising or other communication 
                            materials.
Sec. 1119. Awards for demonstration programs by local partnerships to 
                            coerce abstinence in chronic hard-drug 
                            users under community supervision through 
                            the use of drug testing and sanctions.
Sec. 1120. Policy relating to syringe exchange programs.

  TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND 
                       ROLES AND RESPONSIBILITIES

SEC. 101. AMENDMENTS TO DEFINITIONS.

    (a) Demand Reduction.--Section 702(1) is amended--
            (1) in subparagraph (F), by striking ``and'' after the 
        semicolon;
            (2) in paragraph (G), by striking the period at the end and 
        inserting ``, including the testing of employees;''; and
            (3) by adding at the end the following:
                    ``(H) interventions for drug abuse and dependence;
                    ``(I) international drug control coordination and 
                cooperation with respect to activities described in 
                this paragraph; and
                    ``(J) international drug abuse education, 
                prevention, treatment, research, rehabilitation 
                activities, and interventions for drug abuse and 
                dependence.''.
    (b) National Drug Control Program.--Section 702(6) is amended by 
adding before the period the following: ``, including any activities 
involving supply reduction, demand reduction, or State, local, and 
tribal affairs''.
    (c) Program Change.--Section 702(7) is amended by--
            (1) striking ``National Foreign Intelligence Program,'' and 
        inserting ``National Intelligence Program,''; and
            (2) inserting after ``Related Activities,'' the following: 
        ``or (for purposes of section 704(d)) an agency that is 
        described in section 530C(a) of title 28, United States 
        Code,''.
    (d) Office.--Section 702(9) is amended by striking ``implicates'' 
and inserting ``indicates''.
    (e) State, Local, and Tribal Affairs.--Paragraph (10) of section 
702 is amended to read as follows:
            ``(10) State, local, and tribal affairs.--The term `State, 
        local, and tribal affairs' means domestic activities conducted 
        by a National Drug Control Program agency that are intended to 
        reduce the availability and use of illegal drugs, including--
                    ``(A) coordination and enhancement of Federal, 
                State, local, and tribal law enforcement drug control 
                efforts;
                    ``(B) coordination and enhancement of efforts among 
                National Drug Control Program agencies and State, 
                local, and tribal demand reduction and supply reduction 
                agencies;
                    ``(C) coordination and enhancement of Federal, 
                State, local, and tribal law enforcement initiatives to 
                gather, analyze, and disseminate information and law 
                enforcement intelligence relating to drug control among 
                domestic law enforcement agencies; and
                    ``(D) other coordinated and joint initiatives among 
                Federal, State, local, and tribal agencies to promote 
                comprehensive drug control strategies designed to 
                reduce the demand for, and the availability of, illegal 
                drugs.''.
    (f) Supply Reduction.--Section 702(11) is amended to read as 
follows:
            ``(11) Supply reduction.--The term `supply reduction' means 
        any activity or program conducted by a National Drug Control 
        Program agency that is intended to reduce the availability or 
        use of illegal drugs in the United States or abroad, 
        including--
                    ``(A) law enforcement outside the United States;
                    ``(B) source country programs, including economic 
                development programs primarily intended to reduce the 
                production or trafficking of illicit drugs;
                    ``(C) activities to control international 
                trafficking in, and availability of, illegal drugs, 
                including--
                            ``(i) accurate assessment and monitoring of 
                        international drug production and interdiction 
                        programs and policies; and
                            ``(ii) coordination and promotion of 
                        compliance with international treaties relating 
                        to the production, transportation, or 
                        interdiction of illegal drugs;
                    ``(D) activities to conduct and promote 
                international law enforcement programs and policies to 
                reduce the supply of drugs; and
                    ``(E) activities to facilitate and enhance the 
                sharing of domestic and foreign intelligence 
                information among National Drug Control Program 
                agencies, relating to the production and trafficking of 
                drugs in the United States and in foreign countries.''.
    (g) Definitions of Appropriate Congressional Committees and Law 
Enforcement.--Section 702 is amended by adding at the end the 
following:
            ``(12) Appropriate congressional committees.--Except where 
        otherwise provided, the term `appropriate congressional 
        committees' means the Committee on the Judiciary, the Committee 
        on Appropriations, and the Caucus on International Narcotics 
        Control of the Senate and the Committee on Government Reform, 
        the Committee on the Judiciary, and the Committee on 
        Appropriations of the House of Representatives.
            ``(13) Law enforcement.--The term `law enforcement' or 
        `drug law enforcement' means all efforts by a Federal, State, 
        local, or tribal government agency to enforce the drug laws of 
        the United States or any State, including investigation, 
        arrest, prosecution, and incarceration or other punishments or 
        penalties.''.

SEC. 102. ESTABLISHMENT OF THE OFFICE OF NATIONAL DRUG CONTROL POLICY.

    (a) Responsibilities.--Section 703(a) is amended to read as 
follows:
    ``(a) Establishment of Office.--There is established in the 
Executive Office of the President an Office of National Drug Control 
Policy, which shall--
            ``(1) develop national drug control policy;
            ``(2) coordinate and oversee the implementation of the 
        national drug control policy;
            ``(3) assess and certify the adequacy of National Drug 
        Control Programs and the budget for those programs; and
            ``(4) evaluate the effectiveness of the national drug 
        control policy and the National Drug Control Program agencies' 
        programs, by developing and applying specific goals and 
        performance measurements.''.
    (b) Positions.--Section 703(b) is amended to read as follows:
    ``(b) Director of National Drug Control Policy and Deputy 
Directors.--
            ``(1) Director.--There shall be a Director of National Drug 
        Control Policy who shall head the Office (referred to in this 
        Act as the `Director') and shall hold the same rank and status 
        as the head of an executive department listed in section 101 of 
        title 5, United States Code.
            ``(2) Deputy director.--There shall be a Deputy Director of 
        National Drug Control Policy who shall report directly to the 
        Director (referred to in this Act as the `Deputy Director').
            ``(3) Other deputy directors.--
                    ``(A) In general.--There shall be a Deputy Director 
                for Demand Reduction, a Deputy Director for Supply 
                Reduction, and a Deputy Director for State, Local, and 
                Tribal Affairs.
                    ``(B) Reporting.--The Deputy Director for Demand 
                Reduction, the Deputy Director for Supply Reduction, 
                and the Deputy Director for State, Local, and Tribal 
                Affairs shall report directly to the Deputy Director of 
                the Office of National Drug Control Policy.
                    ``(C) Deputy director for demand reduction.--The 
                Deputy Director for Demand Reduction shall be 
                responsible for the activities in subparagraphs (A) 
                through (H) of section 702(l).
                    ``(D) Deputy director for supply reduction.--The 
                Deputy Director for Supply Reduction shall--
                            ``(i) have substantial experience and 
                        expertise in drug interdiction and other supply 
                        reduction activities; and
                            ``(ii) be responsible for the activities in 
                        subparagraphs (A) through (C) in section 
                        702(11).
                    ``(E) Deputy director for state, local, and tribal 
                affairs.--The Deputy Director for State, Local, and 
                Tribal Affairs shall be responsible for the 
                activities--
                            ``(i) in subparagraphs (A) through (D) of 
                        section 702(10);
                            ``(ii) in section 707, the High Intensity 
                        Drug Trafficking Areas Program; and
                            ``(iii) in section 708, the Counterdrug 
                        Technology Assessment Center.''.

SEC. 103. APPOINTMENT AND RESPONSIBILITIES OF THE DIRECTOR.

    (a) Succession.--Section 704(a) is amended by amending paragraph 
(3) to read as follows:
            ``(3) Acting director.--If the Director dies, resigns, or 
        is otherwise unable to perform the functions and duties of the 
        office, the Deputy Director shall perform the functions and 
        duties of the Director temporarily in an acting capacity 
        pursuant to subchapter III of chapter 33 of title 5, United 
        States Code.''.
    (b) Responsibilities.--Section 704(b) is amended--
            (1) in paragraph (4), by striking ``Federal departments and 
        agencies engaged in drug enforcement'' and inserting ``National 
        Drug Control Program agencies'';
            (2) in paragraph (7), by inserting after ``President'' the 
        following: ``and the appropriate congressional committees'';
            (3) in paragraph (13), by striking ``(beginning in 1999)'';
            (4) by striking paragraph (14) and inserting the following:
            ``(14) shall submit to the appropriate congressional 
        committees on an annual basis, not later than 60 days after the 
        date of the last day of the applicable period, a summary of--
                    ``(A) each of the evaluations received by the 
                Director under paragraph (13); and
                    ``(B) the progress of each National Drug Control 
                Program agency toward the drug control program goals of 
                the agency using the performance measures for the 
                agency developed under section 706(c);'';
            (5) in paragraph (15), by striking subparagraph (C) and 
        inserting the following:
                    ``(C) supporting the substance abuse information 
                clearinghouse administered by the Administrator of the 
                Substance Abuse and Mental Health Services 
                Administration and established in section 501(d)(16) of 
                the Public Health Service Act by--
                            ``(i) encouraging all National Drug Control 
                        Program agencies to provide all appropriate and 
                        relevant information; and
                            ``(ii) supporting the dissemination of 
                        information to all interested entities;''; and
            (6) by inserting at the end the following:
            ``(16) shall coordinate with the private sector to promote 
        private research and development of medications to treat 
        addiction;
            ``(17) shall seek the support and commitment of State, 
        local, and tribal officials in the formulation and 
        implementation of the National Drug Control Strategy;
            ``(18) shall monitor and evaluate the allocation of 
        resources among Federal law enforcement agencies in response to 
        significant local and regional drug trafficking and production 
        threats;
            ``(19) shall submit an annual report to Congress detailing 
        how the Office of National Drug Control Policy has consulted 
        with and assisted State, local, and tribal governments with 
        respect to the formulation and implementation of the National 
        Drug Control Strategy and other relevant issues; and
            ``(20) shall, within 1 year after the date of the enactment 
        of the Office of National Drug Control Policy Reauthorization 
        Act of 2006, report to Congress on the impact of each Federal 
        drug reduction strategy upon the availability, addiction rate, 
        use rate, and other harms of illegal drugs.''.
    (c) Review and Certification of National Drug Control Program 
Budget.--Section 704(c)(3) is amended--
            (1) in subparagraph (C)(iii), by inserting ``and the 
        appropriate congressional committees,'' after ``House of 
        Representatives''; and
            (2) in subparagraph (D)(ii)(II)(bb), by inserting ``and the 
        appropriate congressional committees,'' after ``House of 
        Representatives''.
    (d) Powers of Director.--Section 704(d) is amended--
            (1) in paragraph (9), by striking ``Strategy; and'' and 
        inserting ``Strategy and notify the appropriate congressional 
        committees of any fund control notice issued in accordance with 
        section 704(f)(5);''; and
            (2) in paragraph (10), by inserting before the period the 
        following: ``and section 706 of the Department of State 
        Authorization Act for Fiscal Year 2003 (22 U.S.C. 229j-1)''.
    (e) Fund Control Notices.--Section 704(f) is amended by adding at 
the end the following:
            ``(4) Congressional notice.--A copy of each fund control 
        notice shall be transmitted to the appropriate congressional 
        committees.
            ``(5) Restrictions.--The Director shall not issue a fund 
        control notice to direct that all or part of an amount 
        appropriated to the National Drug Control Program agency 
        account be obligated, modified, or altered in any manner--
                    ``(A) contrary, in whole or in part, to a specific 
                appropriation; or
                    ``(B) contrary, in whole or in part, to the 
                expressed intent of Congress.''.
    (f) Drug Interdiction.--
            (1) In general.--Section 711 is amended by adding at the 
        end the following:

``SEC. 711. DRUG INTERDICTION COORDINATOR AND COMMITTEE.

    ``(a) United States Interdiction Coordinator.--
            ``(1) In general.--The United States Interdiction 
        Coordinator shall perform the duties of that position described 
        in paragraph (2) and such other duties as may be determined by 
        the Director with respect to coordination of efforts to 
        interdict illicit drugs from entering the United States.
            ``(2) Responsibilities.--The United States Interdiction 
        Coordinator shall be responsible to the Director for--
                    ``(A) coordinating the interdiction activities of 
                the National Drug Control Program agencies to ensure 
                consistency with the National Drug Control Strategy;
                    ``(B) on behalf of the Director, developing and 
                issuing, on or before March 1 of each year and in 
                accordance with paragraph (3), a National Interdiction 
                Command and Control Plan to ensure the coordination and 
                consistency described in subparagraph (A);
                    ``(C) assessing the sufficiency of assets committed 
                to illicit drug interdiction by the relevant National 
                Drug Control Program agencies; and
                    ``(D) advising the Director on the efforts of each 
                National Drug Control Program agency to implement the 
                National Interdiction Command and Control Plan.
            ``(3) Staff.--The Director shall assign such permanent 
        staff of the Office as he considers appropriate to assist the 
        United States Interdiction Coordinator to carry out the 
        responsibilities described in paragraph (2), and may also, at 
        his discretion, request that appropriate National Drug Control 
        Program agencies detail or assign staff to the Office of Supply 
        Reduction for that purpose.
            ``(4) National interdiction command and control plan.--
                    ``(A) Purposes.--The National Interdiction Command 
                and Control Plan shall--
                            ``(i) set forth the Government's strategy 
                        for drug interdiction;
                            ``(ii) state the specific roles and 
                        responsibilities of the relevant National Drug 
                        Control Program agencies for implementing that 
                        strategy; and
                            ``(iii) identify the specific resources 
                        required to enable the relevant National Drug 
                        Control Program agencies to implement that 
                        strategy.
                    ``(B) Consultation with other agencies.--The United 
                States Interdiction Coordinator shall issue the 
                National Interdiction Command and Control Plan in 
                consultation with the other members of the Interdiction 
                Committee described in subsection (b).
                    ``(C) Limitation.--The National Interdiction 
                Command and Control Plan shall not change existing 
                agency authorities or the laws governing interagency 
                relationships, but may include recommendations about 
                changes to such authorities or laws.
                    ``(D) Report to congress.--On or before March 1 of 
                each year, the United States Interdiction Coordinator 
                shall provide a report on behalf of the Director to the 
                appropriate congressional committees, to the Committee 
                on Armed Services and the Committee on Homeland 
                Security of the House of Representatives, and to the 
                Committee on Homeland Security and Governmental Affairs 
                and the Committee on Armed Services of the Senate, 
                which shall include--
                            ``(i) a copy of that year's National 
                        Interdiction Command and Control Plan;
                            ``(ii) information for the previous 10 
                        years regarding the number and type of seizures 
                        of drugs by each National Drug Control Program 
                        agency conducting drug interdiction activities, 
                        as well as statistical information on the 
                        geographic areas of such seizures; and
                            ``(iii) information for the previous 10 
                        years regarding the number of air and maritime 
                        patrol hours undertaken by each National Drug 
                        Control Program agency conducting drug 
                        interdiction activities, as well as statistical 
                        information on the geographic areas in which 
                        such patrol hours took place.
                    ``(E) Treatment of classified or law enforcement 
                sensitive information.--Any content of the report 
                described in subparagraph (D) that involves information 
                classified under criteria established by an Executive 
                order, or the public disclosure of which, as determined 
                by the Director, the Director of National Intelligence, 
                or the head of any Federal Government agency the 
                activities of which are described in the plan, would be 
                detrimental to the law enforcement or national security 
                activities of any Federal, State, or local agency, 
                shall be presented to Congress separately from the rest 
                of the report.
    ``(b) Interdiction Committee.--
            ``(1) In general.--The Interdiction Committee shall meet 
        to--
                    ``(A) discuss and resolve issues related to the 
                coordination, oversight and integration of 
                international, border, and domestic drug interdiction 
                efforts in support of the National Drug Control 
                Strategy;
                    ``(B) review the annual National Interdiction 
                Command and Control Plan, and provide advice to the 
                Director and the United States Interdiction Coordinator 
                concerning that plan; and
                    ``(C) provide such other advice to the Director 
                concerning drug interdiction strategy and policies as 
                the committee determines is appropriate.
            ``(2) Chairman.--The Director shall designate one of the 
        members of the Interdiction Committee to serve as chairman.
            ``(3) Meetings.--The members of the Interdiction Committee 
        shall meet, in person and not through any delegate or 
        representative, at least once per calendar year, prior to March 
        1. At the call of either the Director or the current chairman, 
        the Interdiction Committee may hold additional meetings, which 
        shall be attended by the members either in person, or through 
        such delegates or representatives as they may choose.
            ``(4) Report.--Not later than September 30 of each year, 
        the chairman of the Interdiction Committee shall submit a 
        report to the Director and to the appropriate congressional 
        committees describing the results of the meetings and any 
        significant findings of the Committee during the previous 12 
        months. Any content of such a report that involves information 
        classified under criteria established by an Executive order, or 
        whose public disclosure, as determined by the Director, the 
        chairman, or any member, would be detrimental to the law 
        enforcement or national security activities of any Federal, 
        State, local, or tribal agency, shall be presented to Congress 
        separately from the rest of the report. by striking subsection 
        (d) and redesignating subsections (e), (f), and (g) as 
        subsections (d), (e), and (f), respectively.''.
            (2) Conforming amendment to homeland security act of 
        2002.--Section 878 of the Homeland Security Act of 2002 (6 
        U.S.C. 458) is amended--
                    (A) in subsection (c), by striking ``Except as 
                provided in subsection (d), the'' and inserting 
                ``The''; and
                    (B) by striking subsection (d) and redesignating 
                subsections (e), (f), and (g) as subsections (d), (e), 
                and (f), respectively.
            (3) Technical amendments.--Section 704 (21 U.S.C. 1703) is 
        amended--
                    (A) by amending subsection (g) to read as follows:
    ``(g) Inapplicability to Certain Programs.--The provisions of this 
section shall not apply to the National Intelligence Program, the Joint 
Military Intelligence Program, and Tactical and Related Activities, 
unless such program or an element of such program is designated as a 
National Drug Control Program--
            ``(1) by the President; or
            ``(2) jointly by--
                    ``(A) in the case of the National Intelligence 
                Program, the Director and the Director of National 
                Intelligence; or
                    ``(B) in the case of the Joint Military 
                Intelligence Program and Tactical and Related 
                Activities, the Director, the Director of National 
                Intelligence, and the Secretary of Defense.''; and
                    (B) by amending subsection (h) to read as follows:
    ``(h) Construction.--Nothing in this Act shall be construed as 
derogating the authorities and responsibilities of the Director of 
National Intelligence or the Director of the Central Intelligence 
Agency contained in the National Security Act of 1947 (50 U.S.C. 401 et 
seq.), the Central Intelligence Agency Act of 1949 (50 U.S.C. 403a et 
seq.), or any other law.''.

SEC. 104. AMENDMENTS TO ENSURE COORDINATION WITH OTHER AGENCIES.

    Section 705 is amended--
            (1) in subsection (a)(1)(A), by striking ``abuse'';
            (2) in subsection (a)(2)(A), by striking ``Director of 
        Central Intelligence'' and inserting ``Director of National 
        Intelligence'';
            (3) in subsection (a)(2)(B), by striking ``Director of 
        Central Intelligence'' and inserting ``Director of National 
        Intelligence and the Director of the Central Intelligence 
        Agency'';
            (4) by amending subsection (a)(3) to read as follows:
            ``(3) Required reports.--
                    ``(A) Secretaries of the interior and 
                agriculture.--Not later than July 1 of each year, the 
                Secretaries of Agriculture and the Interior shall 
                jointly submit to the Director and the appropriate 
                congressional committees an assessment of the quantity 
                of illegal drug cultivation and manufacturing in the 
                United States on lands owned or under the jurisdiction 
                of the Federal Government for the preceding year.
                    ``(B) Secretary of homeland security.--Not later 
                than July 1 of each year, the Secretary of Homeland 
                Security shall submit to the Director and the 
                appropriate congressional committees information for 
                the preceding year regarding--
                            ``(i) the number and type of seizures of 
                        drugs by each component of the Department of 
                        Homeland Security seizing drugs, as well as 
                        statistical information on the geographic areas 
                        of such seizures; and
                            ``(ii) the number of air and maritime 
                        patrol hours primarily dedicated to drug supply 
                        reduction missions undertaken by each component 
                        of the Department of Homeland Security.
                    ``(C) Secretary of defense.--The Secretary of 
                Defense shall, by July 1 of each year, submit to the 
                Director and the appropriate congressional committees 
                information for the preceding year regarding the number 
                of air and maritime patrol hours primarily dedicated to 
                drug supply reduction missions undertaken by each 
                component of the Department of Defense.
                    ``(D) Attorney general.--The Attorney General 
                shall, by July 1 of each year, submit to the Director 
                and the appropriate congressional committees 
                information for the preceding year regarding the number 
                and type of--
                            ``(i) arrests for drug violations;
                            ``(ii) prosecutions for drug violations by 
                        United States Attorneys; and
                            ``(iii) seizures of drugs by each component 
                        of the Department of Justice seizing drugs, as 
                        well as statistical information on the 
                        geographic areas of such seizures.'';
            (5) in subsection (b)(2)(B), by striking ``Program'' and 
        inserting ``Strategy''; and
            (6) in subsection (c), by striking ``in'' and inserting 
        ``on''.

SEC. 105. BUDGETARY MATTERS.

    (a) Submission of Drug Control Budget Requests.--Section 704(c)(1) 
is amended by adding at the end the following:
                    ``(C) Content of drug control budget requests.--A 
                drug control budget request submitted by a department, 
                agency, or program under this paragraph shall include 
                all requests for funds for any drug control activity 
                undertaken by that department, agency, or program, 
                including demand reduction, supply reduction, and 
                State, local, and tribal affairs, including any drug 
                law enforcement activities. If an activity has both 
                drug control and nondrug control purposes or 
                applications, the department, agency, or program shall 
                estimate by a documented calculation the total funds 
                requested for that activity that would be used for drug 
                control, and shall set forth in its request the basis 
                and method for making the estimate.''.
    (b) National Drug Control Budget Proposal.--
            (1) National organizations.--Section 704(c)(2) is amended 
        by inserting ``and the head of each major national organization 
        that represents law enforcement officers, agencies, or 
        associations'' after ``agency''.
            (2) Total budget.--Section 704(c)(2)(A) is amended by 
        inserting before the semicolon: ``and to inform Congress and 
        the public about the total amount proposed to be spent on all 
        supply reduction, demand reduction, State, local, and tribal 
        affairs, including any drug law enforcement, and other drug 
        control activities by the Federal Government, which shall 
        conform to the content requirements set forth in paragraph 
        (1)(C)''.
    (c) Review and Certification of National Drug Control Program 
Budget.--Section 704(c)(3) is amended--
            (1) by redesignating subparagraphs (C) and (D) as 
        subparagraphs (D) and (E), respectively;
            (2) by inserting after subparagraph (B) the following new 
        subparagraph:
                    ``(C) Specific requests.--The Director shall not 
                confirm the adequacy of any budget request that--
                            ``(i) requests funding for Federal law 
                        enforcement activities that do not adequately 
                        compensate for transfers of drug enforcement 
                        resources and personnel to law enforcement and 
                        investigation activities;
                            ``(ii) requests funding for law enforcement 
                        activities on the borders of the United States 
                        that do not adequately direct resources to drug 
                        interdiction and enforcement;
                            ``(iii) requests funding for drug treatment 
                        activities that do not provide adequate results 
                        and accountability measures;
                            ``(iv) requests funding for any activities 
                        of the Safe and Drug-Free Schools Program that 
                        do not include a clear anti-drug message or 
                        purpose intended to reduce drug use;
                            ``(v) requests funding for drug treatment 
                        activities that do not adequately support and 
                        enhance Federal drug treatment programs and 
                        capacity;
                            ``(vi) requests funding for fiscal year 
                        2007 for activities of the Department of 
                        Education, unless it is accompanied by a report 
                        setting forth a plan for providing expedited 
                        consideration of student loan applications for 
                        all individuals who submitted an application 
                        for any Federal grant, loan, or work assistance 
                        that was rejected or denied pursuant to 
                        484(r)(1) of the Higher Education Act of 1965 
                        (20 U.S.C. 1091(r)(1)) by reason of a 
                        conviction for a drug-related offense not 
                        occurring during a period of enrollment for 
                        which the individual was receiving any Federal 
                        grant, loan, or work assistance; and
                            ``(vii) requests funding for the operations 
                        and management of the Department of Homeland 
                        Security that does not include a specific 
                        request for funds for the Office of 
                        Counternarcotics Enforcement to carry out its 
                        responsibilities under section 878 of the 
                        Homeland Security Act of 2002 (6 U.S.C. 
                        458).'';
            (3) in subparagraph (D)(iii), as so redesignated, by 
        inserting ``and the appropriate congressional committees'' 
        after ``House of Representatives''; and
            (4) in subparagraph (E)(ii)(II)(bb), as so redesignated, by 
        inserting ``and the appropriate congressional committees'' 
        after ``House of Representatives''.
    (d) Reprogramming and Transfer Requests.--Section 704(c)(4)(A) (21 
U.S.C. 1703(c)(4)(A)) is amended--
            (1) by striking ``$5,000,000'' and inserting 
        ``$1,000,000''; and
            (2) adding at the end the following: ``If the Director has 
        not responded to a request for reprogramming subject to this 
        subparagraph within 30 days after receiving notice of the 
        request having been made, the request shall be deemed approved 
        by the Director under this subparagraph and forwarded to 
        Congress.''.
    (e) Powers of Director.--Section 704(d) is amended--
            (1) in paragraph (8)(D), by striking ``have been authorized 
        by Congress;'' and inserting ``authorized by law;'';
            (2) in paragraph (9), by striking ``Strategy; and'' and 
        inserting ``Strategy and notify the appropriate congressional 
        committees of any fund control notice issued; and''; and
            (3) in paragraph (10), by striking ``(22 U.S.C. 2291j).'' 
        and inserting ``(22 U.S.C. 2291j) and section 706 of the 
        Foreign Relations Authorization Act, Fiscal Year 2003 (22 
        U.S.C. 2291j-1).''.
    (f) Fund Control Notices.--Section 704(f) (21 U.S.C. 1703(f)) is 
amended by adding at the end the following:
            ``(4) Congressional notice.--A copy of each fund control 
        notice shall be transmitted to the appropriate congressional 
        committees.
            ``(5) Restrictions.--The Director shall not issue a fund 
        control notice to direct that all or part of an amount 
        appropriated to the National Drug Control Program agency 
        account be obligated, modified, or altered in any manner 
        contrary, in whole or in part, to a specific appropriation or 
        statute.''.

              TITLE II--THE NATIONAL DRUG CONTROL STRATEGY

SEC. 201. ANNUAL PREPARATION AND SUBMISSION OF NATIONAL DRUG CONTROL 
              STRATEGY.

    Section 706 is amended to read as follows:

``SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, AND ASSESSMENT OF 
              NATIONAL DRUG CONTROL STRATEGY.

    ``(a) Timing, Contents, and Process for Development and Submission 
of National Drug Control Strategy.--
            ``(1) Timing.--Not later than February 1 of each year, the 
        President shall submit to Congress a National Drug Control 
        Strategy, which shall set forth a comprehensive plan for the 
        year to reduce illicit drug use and the consequences of such 
        illicit drug use in the United States by limiting the 
        availability of, and reducing the demand for, illegal drugs.
            ``(2) Contents.--
                    ``(A) In general.--The National Drug Control 
                Strategy submitted under paragraph (1) shall include 
                the following:
                            ``(i) Comprehensive, research-based, long-
                        range, quantifiable goals for reducing illicit 
                        drug use and the consequences of illicit drug 
                        use in the United States.
                            ``(ii) Annual quantifiable and measurable 
                        objectives and specific targets to accomplish 
                        long-term quantifiable goals that the Director 
                        determines may be achieved during each year 
                        beginning on the date on which the National 
                        Drug Control Strategy is submitted.
                            ``(iii) A 5-year projection for program and 
                        budget priorities.
                            ``(iv) A review of international, State, 
                        local, and private sector drug control 
                        activities to ensure that the United States 
                        pursues coordinated and effective drug control 
                        at all levels of government.
                            ``(v) An assessment of current illicit drug 
                        use (including inhalants and steroids) and 
                        availability, impact of illicit drug use, and 
                        treatment availability, which assessment shall 
                        include--
                                    ``(I) estimates of drug prevalence 
                                and frequency of use as measured by 
                                national, State, and local surveys of 
                                illicit drug use and by other special 
                                studies of nondependent and dependent 
                                illicit drug use;
                                    ``(II) illicit drug use in the 
                                workplace and the productivity lost by 
                                such use; and
                                    ``(III) illicit drug use by 
                                arrestees, probationers, and parolees.
                            ``(vi) An assessment of the reduction of 
                        illicit drug availability, as measured by--
                                    ``(I) the quantities of cocaine, 
                                heroin, marijuana, methamphetamine, 
                                ecstasy, and other drugs available for 
                                consumption in the United States;
                                    ``(II) the amount of marijuana, 
                                cocaine, heroin, methamphetamine, 
                                ecstasy, and precursor chemicals and 
                                other drugs entering the United States;
                                    ``(III) the number of illicit drug 
                                manufacturing laboratories seized and 
                                destroyed and the number of hectares of 
                                marijuana, poppy, and coca cultivated 
                                and destroyed domestically and in other 
                                countries;
                                    ``(IV) the number of metric tons of 
                                marijuana, heroin, cocaine, and 
                                methamphetamine seized and other drugs; 
                                and
                                    ``(V) changes in the price and 
                                purity of heroin, methamphetamine, and 
                                cocaine, changes in the price of 
                                ecstasy, and changes in 
                                tetrahydrocannabinol level of marijuana 
                                and other drugs.
                            ``(vii) An assessment of the reduction of 
                        the consequences of illicit drug use and 
                        availability, which shall include--
                                    ``(I) the burden illicit drug users 
                                placed on hospital emergency 
                                departments in the United States, such 
                                as the quantity of illicit drug-related 
                                services provided;
                                    ``(II) the annual national health 
                                care cost of illicit drug use; and
                                    ``(III) the extent of illicit drug-
                                related crime and criminal activity.
                            ``(viii) A determination of the status of 
                        drug treatment in the United States, by 
                        assessing--
                                    ``(I) public and private treatment 
                                utilization; and
                                    ``(II) the number of illicit drug 
                                users the Director estimates meet 
                                diagnostic criteria for treatment.
                            ``(ix) A review of the research agenda of 
                        the Counterdrug Technology Assessment Center to 
                        reduce the availability and abuse of drugs.
                            ``(x) A summary of the efforts made to 
                        coordinate with private sector entities to 
                        conduct private research and development of 
                        medications to treat addiction by--
                                    ``(I) screening chemicals for 
                                potential therapeutic value;
                                    ``(II) developing promising 
                                compounds;
                                    ``(III) conducting clinical trials;
                                    ``(IV) seeking Food and Drug 
                                Administration approval for drugs to 
                                treat addiction;
                                    ``(V) marketing the drug for the 
                                treatment of addiction;
                                    ``(VI) urging physicians to use the 
                                drug in the treatment of addiction; and
                                    ``(VII) encouraging insurance 
                                companies to reimburse the cost of the 
                                drug for the treatment of addiction.
                            ``(xi) An assessment of Federal 
                        effectiveness in achieving the National Drug 
                        Control Strategy for the previous year, 
                        including a specific evaluation of whether the 
                        objectives and targets for reducing illicit 
                        drug use for the previous year were met and 
                        reasons for the success or failure of the 
                        previous year's Strategy.
                            ``(xii) A general review of the status of, 
                        and trends in, demand reduction activities by 
                        private sector entities and community-based 
                        organizations, including faith-based 
                        organizations, to determine their effectiveness 
                        and the extent of cooperation, coordination, 
                        and mutual support between such entities and 
                        organizations and Federal, State, local, and 
                        tribal government agencies.
                            ``(xiii) Such additional statistical data 
                        and information as the Director considers 
                        appropriate to demonstrate and assess trends 
                        relating to illicit drug use, the effects and 
                        consequences of illicit drug use (including the 
                        effects on children of substance abusers), 
                        supply reduction, demand reduction, drug-
                        related law enforcement, and the implementation 
                        of the National Drug Control Strategy.
                            ``(xiv) A supplement reviewing the 
                        activities of each individual National Drug 
                        Control Program agency during the previous year 
                        with respect to the National Drug Control 
                        Strategy and the Director's assessment of the 
                        progress of each National Drug Control Program 
                        agency in meeting its responsibilities under 
                        the National Drug Control Strategy.
                    ``(B) Classified information.--Any contents of the 
                National Drug Control Strategy that involve information 
                properly classified under criteria established by an 
                Executive order shall be presented to Congress 
                separately from the rest of the National Drug Control 
                Strategy.
                    ``(C) Selection of data and information.--In 
                selecting data and information for inclusion under 
                subparagraph (A), the Director shall ensure--
                            ``(i) the inclusion of data and information 
                        that will permit analysis of current trends 
                        against previously compiled data and 
                        information where the Director believes such 
                        analysis enhances long-term assessment of the 
                        National Drug Control Strategy; and
                            ``(ii) the inclusion of data and 
                        information to permit a standardized and 
                        uniform assessment of the effectiveness of drug 
                        treatment programs in the United States.
            ``(3) Process for development and submission.--In 
        developing and effectively implementing the National Drug 
        Control Strategy, the Director--
                    ``(A) shall consult with--
                            ``(i) the heads of the National Drug 
                        Control Program agencies;
                            ``(ii) Congress;
                            ``(iii) State, local, and tribal officials;
                            ``(iv) private citizens and organizations, 
                        including community and faith-based 
                        organizations with experience and expertise in 
                        demand reduction;
                            ``(v) private citizens and organizations 
                        with experience and expertise in supply 
                        reduction; and
                            ``(vi) appropriate representatives of 
                        foreign governments;
                    ``(B) in satisfying the requirements of 
                subparagraph (A), shall ensure, to the maximum extent 
                possible, that State, local, and tribal officials and 
                relevant private organizations commit to support and 
                take steps to achieve the goals and objectives of the 
                National Drug Control Strategy;
                    ``(C) with the concurrence of the Attorney General, 
                may require the El Paso Intelligence Center to 
                undertake specific tasks or projects to support or 
                implement the National Drug Control Strategy; and
                    ``(D) with the concurrence of the Director of 
                National Intelligence and the Attorney General, may 
                request that the National Drug Intelligence Center 
                undertake specific tasks or projects to support or 
                implement the National Drug Control Strategy.
    ``(b) Submission of Revised Strategy.--The President may submit to 
Congress a revised National Drug Control Strategy that meets the 
requirements of this section--
            ``(1) at any time, upon a determination of the President, 
        in consultation with the Director, that the National Drug 
        Control Strategy in effect is not sufficiently effective; or
            ``(2) if a new President or Director takes office.''.

SEC. 202. PERFORMANCE MEASUREMENTS.

    Section 706 is amended by adding at the end the following:
    ``(c) Performance Measurement System.--Not later than February 1 of 
each year, the Director shall submit to Congress as part of the 
National Drug Control Strategy, a description of a national drug 
control performance measurement system, that--
            ``(1) develops 2-year and 5-year performance measures and 
        targets for each National Drug Control Strategy goal and 
        objective established for reducing drug use, availability, and 
        the consequences of drug use;
            ``(2) describes the sources of information and data that 
        will be used for each performance measure incorporated into the 
        performance measurement system;
            ``(3) identifies major programs and activities of the 
        National Drug Control Program agencies that support the goals 
        and annual objectives of the National Drug Control Strategy;
            ``(4) evaluates the contribution of demand reduction and 
        supply reduction activities as defined in section 702 
        implemented by each National Drug Control Program agency in 
        support of the National Drug Control Strategy;
            ``(5) monitors consistency between the drug-related goals 
        and objectives of the National Drug Control Program agencies 
        and ensures that each agency's goals and budgets support and 
        are fully consistent with the National Drug Control Strategy; 
        and
            ``(6) coordinates the development and implementation of 
        national drug control data collection and reporting systems to 
        support policy formulation and performance measurement, 
        including an assessment of--
                    ``(A) the quality of current drug use measurement 
                instruments and techniques to measure supply reduction 
                and demand reduction activities;
                    ``(B) the adequacy of the coverage of existing 
                national drug use measurement instruments and 
                techniques to measure the illicit drug user population, 
                and groups that are at risk for illicit drug use;
                    ``(C) the adequacy of the coverage of existing 
                national treatment outcome monitoring systems to 
                measure the effectiveness of drug abuse treatment in 
                reducing illicit drug use and criminal behavior during 
                and after the completion of substance abuse treatment; 
                and
                    ``(D) the actions the Director shall take to 
                correct any deficiencies and limitations identified 
                pursuant to subparagraphs (A) and (B) of this 
                subsection.
    ``(d) Modifications.--A description of any modifications made 
during the preceding year to the national drug performance measurement 
system described in subsection (c) shall be included in each report 
submitted under subsection (b).''.

SEC. 203. ANNUAL REPORT REQUIREMENT.

    (a) In General.--On or before February 1 of each year, the Director 
shall submit a report to Congress that describes--
            (1) the strategy of the national media campaign and whether 
        specific objectives of the campaign were accomplished;
            (2) steps taken to ensure that the national media campaign 
        operates in an effective and efficient manner consistent with 
        the overall strategy and focus of the campaign;
            (3) plans to purchase advertising time and space;
            (4) policies and practices implemented to ensure that 
        Federal funds are used responsibly to purchase advertising time 
        and space and eliminate the potential for waste, fraud, and 
        abuse;
            (5) all contracts entered into with a corporation, 
        partnership, or individual working on behalf of the national 
        media campaign;
            (6) specific policies and steps implemented to ensure 
        compliance with title IV of this Act;
            (7) steps taken to ensure that the national media campaign 
        will secure, to the maximum extent possible, no cost matches of 
        advertising time and space or in-kind contributions that are 
        directly related to the campaign in accordance with title IV of 
        this Act; and
            (8) a review and evaluation of the effectiveness of the 
        national media campaign strategy for the past year.
    (b) Audit.--The Government Accountability Office shall, at a 
frequency of not less than once per year--
            (1) conduct and supervise an audit and investigation 
        relating to the programs and operations of the--
                    (A) Office; or
                    (B) certain programs within the Office, including--
                            (i) the High Intensity Drug Trafficking 
                        Areas Program;
                            (ii) the Counterdrug Technology Assessment 
                        Center; or
                            (iii) the National Youth Anti-drug Media 
                        Campaign; and
            (2) provide the Director and the appropriate congressional 
        committees with a report containing an evaluation of and 
        recommendations on the--
                    (A) policies and activities of the programs and 
                operations subject to the audit and investigation;
                    (B) economy, efficiency, and effectiveness in the 
                administration of the reviewed programs and operations; 
                and
                    (C) policy or management changes needed to prevent 
                and detect fraud and abuse in such programs and 
                operations.

            TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS

SEC. 301. HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.

    Section 707 is amended to read as follows:

``SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.

    ``(a) Establishment.--
            ``(1) In general.--There is established in the Office a 
        program to be known as the High Intensity Drug Trafficking 
        Areas Program (in this section referred to as the `Program').
            ``(2) Purpose.--The purpose of the Program is to reduce 
        drug trafficking and drug production in the United States by--
                    ``(A) facilitating cooperation among Federal, 
                State, local, and tribal law enforcement agencies to 
                share information and implement coordinated enforcement 
                activities;
                    ``(B) enhancing law enforcement intelligence 
                sharing among Federal, State, local, and tribal law 
                enforcement agencies;
                    ``(C) providing reliable law enforcement 
                intelligence to law enforcement agencies needed to 
                design effective enforcement strategies and operations; 
                and
                    ``(D) supporting coordinated law enforcement 
                strategies which maximize use of available resources to 
                reduce the supply of illegal drugs in designated areas 
                and in the United States as a whole.
    ``(b) Designation.--
            ``(1) In general.--The Director, in consultation with the 
        Attorney General, the Secretary of the Treasury, the Secretary 
        of Homeland Security, heads of the National Drug Control 
        Program agencies, and the Governor of each applicable State, 
        may designate any specified area of the United States as a high 
        intensity drug trafficking area.
            ``(2) Activities.--After making a designation under 
        paragraph (1) and in order to provide Federal assistance to the 
        area so designated, the Director may--
                    ``(A) obligate such sums as are appropriated for 
                the Program;
                    ``(B) direct the temporary reassignment of Federal 
                personnel to such area, subject to the approval of the 
                head of the department or agency that employs such 
                personnel;
                    ``(C) take any other action authorized under 
                section 704 to provide increased Federal assistance to 
                those areas; and
                    ``(D) coordinate activities under this section 
                (specifically administrative, recordkeeping, and funds 
                management activities) with State, local, and tribal 
                officials.
    ``(c) Petitions for Designation.--The Director shall establish 
regulations under which a coalition of interested law enforcement 
agencies from an area may petition for designation as a high intensity 
drug trafficking area. Such regulations shall provide for a regular 
review by the Director of the petition, including a recommendation 
regarding the merit of the petition to the Director by a panel of 
qualified, independent experts.
    ``(d) Factors for Consideration.--In considering whether to 
designate an area under this section as a high intensity drug 
trafficking area, the Director shall consider, in addition to such 
other criteria as the Director considers to be appropriate, the extent 
to which--
            ``(1) the area is a significant center of illegal drug 
        production, manufacturing, importation, or distribution;
            ``(2) State, local, and tribal law enforcement agencies 
        have committed resources to respond to the drug trafficking 
        problem in the area, thereby indicating a determination to 
        respond aggressively to the problem;
            ``(3) drug-related activities in the area are having a 
        significant harmful impact in the area, and in other areas of 
        the country; and
            ``(4) a significant increase in allocation of Federal 
        resources is necessary to respond adequately to drug-related 
        activities in the area.
    ``(e) Organization of High Intensity Drug Trafficking Areas.--
            ``(1) Executive board and officers.--To be eligible for 
        funds appropriated under this section, each high intensity drug 
        trafficking area shall be governed by an Executive Board. The 
        Executive Board shall designate a chairman, vice chairman, and 
        any other officers to the Executive Board that it determines 
        are necessary.
            ``(2) Responsibilities.--The Executive Board of a high 
        intensity drug trafficking area shall be responsible for--
                    ``(A) providing direction and oversight in 
                establishing and achieving the goals of the high 
                intensity drug trafficking area;
                    ``(B) managing the funds of the high intensity drug 
                trafficking area;
                    ``(C) reviewing and approving all funding proposals 
                consistent with the overall objective of the high 
                intensity drug trafficking area; and
                    ``(D) reviewing and approving all reports to the 
                Director on the activities of the high intensity drug 
                trafficking area.
            ``(3) Board representation.--None of the funds appropriated 
        under this section may be expended for any high intensity drug 
        trafficking area, or for a partnership or region of a high 
        intensity drug trafficking area, if the Executive Board for 
        such area, region, or partnership, does not apportion an equal 
        number of votes between representatives of participating 
        Federal agencies and representatives of participating State, 
        local, and tribal agencies. Where it is impractical for an 
        equal number of representatives of Federal agencies and State, 
        local, and tribal agencies to attend a meeting of an Executive 
        Board in person, the Executive Board may use a system of proxy 
        votes or weighted votes to achieve the voting balance required 
        by this paragraph.
            ``(4) No agency relationship.--The eligibility requirements 
        of this section are intended to ensure the responsible use of 
        Federal funds. Nothing in this section is intended to create an 
        agency relationship between individual high intensity drug 
        trafficking areas and the Federal Government.
    ``(f) Use of Funds.--The Director shall ensure that no Federal 
funds appropriated for the Program are expended for the establishment 
or expansion of drug treatment programs, and shall ensure that not more 
than 5 percent of the Federal funds appropriated for the Program are 
expended for the establishment of drug prevention programs.
    ``(g) Counterterrorism Activities.--
            ``(1) Assistance authorized.--The Director may authorize 
        use of resources available for the Program to assist Federal, 
        State, local, and tribal law enforcement agencies in 
        investigations and activities related to terrorism and 
        prevention of terrorism, especially but not exclusively with 
        respect to such investigations and activities that are also 
        related to drug trafficking.
            ``(2) Limitation.--The Director shall ensure--
                    ``(A) that assistance provided under paragraph (1) 
                remains incidental to the purpose of the Program to 
                reduce drug availability and carry out drug-related law 
                enforcement activities; and
                    ``(B) that significant resources of the Program are 
                not redirected to activities exclusively related to 
                terrorism, except on a temporary basis under 
                extraordinary circumstances, as determined by the 
                Director.
    ``(h) Role of Drug Enforcement Administration.--The Director, in 
consultation with the Attorney General, shall ensure that a 
representative of the Drug Enforcement Administration is included in 
the Intelligence Support Center for each high intensity drug 
trafficking area.
    ``(i) Annual HIDTA Program Budget Submissions.--As part of the 
documentation that supports the President's annual budget request for 
the Office, the Director shall submit to Congress a budget 
justification that includes--
            ``(1) the amount proposed for each high intensity drug 
        trafficking area, conditional upon a review by the Office of 
        the request submitted by the HIDTA and the performance of the 
        HIDTA, with supporting narrative descriptions and rationale for 
        each request;
            ``(2) a detailed justification that explains--
                    ``(A) the reasons for the proposed funding level; 
                how such funding level was determined based on a 
                current assessment of the drug trafficking threat in 
                each high intensity drug trafficking area;
                    ``(B) how such funding will ensure that the goals 
                and objectives of each such area will be achieved; and
                    ``(C) how such funding supports the National Drug 
                Control Strategy; and
            ``(3) the amount of HIDTA funds used to investigate and 
        prosecute organizations and individuals trafficking in 
        methamphetamine in the prior calendar year, and a description 
        of how those funds were used.
    ``(j) Emerging Threat Response Fund.--
            ``(1) In general.--Subject to the availability of 
        appropriations, the Director may expend up to 10 percent of the 
        amounts appropriated under this section on a discretionary 
        basis, to respond to any emerging drug trafficking threat in an 
        existing high intensity drug trafficking area, or to establish 
        a new high intensity drug trafficking area or expand an 
        existing high intensity drug trafficking area, in accordance 
        with the criteria established under paragraph (2).
            ``(2) Consideration of impact.--In allocating funds under 
        this subsection, the Director shall consider--
                    ``(A) the impact of activities funded on reducing 
                overall drug traffic in the United States, or 
                minimizing the probability that an emerging drug 
                trafficking threat will spread to other areas of the 
                United States; and
                    ``(B) such other criteria as the Director considers 
                appropriate.
    ``(k) Evaluation.--
            ``(1) Initial report.--Not later than 90 days after the 
        date of the enactment of this section, the Director shall, 
        after consulting with the Executive Boards of each designated 
        high intensity drug trafficking area, submit a report to 
        Congress that describes, for each designated high intensity 
        drug trafficking area--
                    ``(A) the specific purposes for the high intensity 
                drug trafficking area;
                    ``(B) the specific long-term and short-term goals 
                and objectives for the high intensity drug trafficking 
                area;
                    ``(C) the measurements that will be used to 
                evaluate the performance of the high intensity drug 
                trafficking area in achieving the long-term and short-
                term goals; and
                    ``(D) the reporting requirements needed to evaluate 
                the performance of the high intensity drug trafficking 
                area in achieving the long-term and short-term goals.
            ``(2) Evaluation of hidta program as part of national drug 
        control strategy.--For each designated high intensity drug 
        trafficking area, the Director shall submit, as part of the 
        annual National Drug Control Strategy report, a report that--
                    ``(A) describes--
                            ``(i) the specific purposes for the high 
                        intensity drug trafficking area; and
                            ``(ii) the specific long-term and short-
                        term goals and objectives for the high 
                        intensity drug trafficking area; and
                    ``(B) includes an evaluation of the performance of 
                the high intensity drug trafficking area in 
                accomplishing the specific long-term and short-term 
                goals and objectives identified under paragraph (1)(B).
    ``(l) Assessment of Drug Enforcement Task Forces in High Intensity 
Drug Trafficking Areas.--Not later than 1 year after the date of 
enactment of this subsection, and as part of each subsequent annual 
National Drug Control Strategy report, the Director shall submit to 
Congress a report--
            ``(1) assessing the number and operation of all federally 
        funded drug enforcement task forces within each high intensity 
        drug trafficking area; and
            ``(2) describing--
                    ``(A) each Federal, State, local, and tribal drug 
                enforcement task force operating in the high intensity 
                drug trafficking area;
                    ``(B) how such task forces coordinate with each 
                other, with any high intensity drug trafficking area 
                task force, and with investigations receiving funds 
                from the Organized Crime and Drug Enforcement Task 
                Force;
                    ``(C) what steps, if any, each such task force 
                takes to share information regarding drug trafficking 
                and drug production with other federally funded drug 
                enforcement task forces in the high intensity drug 
                trafficking area;
                    ``(D) the role of the high intensity drug 
                trafficking area in coordinating the sharing of such 
                information among task forces;
                    ``(E) the nature and extent of cooperation by each 
                Federal, State, local, and tribal participant in 
                ensuring that such information is shared among law 
                enforcement agencies and with the high intensity drug 
                trafficking area;
                    ``(F) the nature and extent to which information 
                sharing and enforcement activities are coordinated with 
                joint terrorism task forces in the high intensity drug 
                trafficking area; and
                    ``(G) any recommendations for measures needed to 
                ensure that task force resources are utilized 
                efficiently and effectively to reduce the availability 
                of illegal drugs in the high intensity drug trafficking 
                areas.
    ``(m) Assessment of Law Enforcement Intelligence Sharing in High 
Intensity Drug Trafficking Areas Program.--Not later than 180 days 
after the date of the enactment of this section, and as part of each 
subsequent annual National Drug Control Strategy report, the Director, 
in consultation with the Director of National Intelligence, shall 
submit to Congress a report--
            ``(1) evaluating existing and planned law enforcement 
        intelligence systems supported by each high intensity drug 
        trafficking area, or utilized by task forces receiving any 
        funding under the Program, including the extent to which such 
        systems ensure access and availability of law enforcement 
        intelligence to Federal, State, local, and tribal law 
        enforcement agencies within the high intensity drug trafficking 
        area and outside of it;
            ``(2) the extent to which Federal, State, local, and tribal 
        law enforcement agencies participating in each high intensity 
        drug trafficking area are sharing law enforcement intelligence 
        information to assess current drug trafficking threats and 
        design appropriate enforcement strategies; and
            ``(3) the measures needed to improve effective sharing of 
        information and law enforcement intelligence regarding drug 
        trafficking and drug production among Federal, State, local, 
        and tribal law enforcement participating in a high intensity 
        drug trafficking area, and between such agencies and similar 
        agencies outside the high intensity drug trafficking area.
    ``(n) Coordination of Law Enforcement Intelligence Sharing With 
Organized Crime Drug Enforcement Task Force Program.--The Director, in 
consultation with the Attorney General, shall ensure that any drug 
enforcement intelligence obtained by the Intelligence Support Center 
for each high intensity drug trafficking area is shared, on a timely 
basis, with the drug intelligence fusion center operated by the 
Organized Crime Drug Enforcement Task Force of the Department of 
Justice.
    ``(o) Use of Funds To Combat Methamphetamine Trafficking.--
            ``(1) Requirement.--As part of the documentation that 
        supports the President's annual budget request for the Office, 
        the Director shall submit to Congress a report describing the 
        use of HIDTA funds to investigate and prosecute organizations 
        and individuals trafficking in methamphetamine in the prior 
        calendar year.
            ``(2) Contents.--The report shall include--
                    ``(A) the number of methamphetamine manufacturing 
                facilities discovered through HIDTA-funded initiatives 
                in the previous fiscal year;
                    ``(B) the amounts of methamphetamine or listed 
                chemicals (as that term is defined in section 102(33) 
                of the Controlled Substances Act (21 U.S.C. 802(33)) 
                seized by HIDTA-funded initiatives in the area during 
                the previous year; and
                    ``(C) law enforcement intelligence and predictive 
                data from the Drug Enforcement Administration showing 
                patterns and trends in abuse, trafficking, and 
                transportation in methamphetamine and listed chemicals.
            ``(3) Certification.--Before the Director awards any funds 
        to a high intensity drug trafficking area, the Director shall 
        certify that the law enforcement entities participating in that 
        HIDTA are providing laboratory seizure data to the national 
        clandestine laboratory database at the El Paso Intelligence 
        Center.
    ``(p) Authorization of Appropriations.--There is authorized to be 
appropriated to the Office of National Drug Control Policy to carry out 
this section--
            ``(1) $240,000,000 for fiscal year 2007;
            ``(2) $250,000,000 for fiscal year 2008;
            ``(3) $260,000,000 for fiscal year 2009;
            ``(4) $270,000,000 for fiscal year 2010; and
            ``(5) $280,000,000 for each of fiscal year 2011.''.

SEC. 302. FUNDING FOR CERTAIN HIGH INTENSITY DRUG TRAFFICKING AREAS.

    (a) Short Title.--This section may be cited as the ``Dawson Family 
Community Protection Act''.
    (b) Findings.--Congress finds the following:
            (1) In the early morning hours of October 16, 2002, the 
        home of Carnell and Angela Dawson was firebombed in apparent 
        retaliation for Mrs. Dawson's notification to police about 
        persistent drug distribution activity in their East Baltimore 
        City neighborhood.
            (2) The arson claimed the lives of Mr. and Mrs. Dawson and 
        their 5 young children, aged 9 to 14.
            (3) The horrific murder of the Dawson family is a stark 
        example of domestic narco-terrorism.
            (4) In all phases of counternarcotics law enforcement--from 
        prevention to investigation to prosecution to reentry--the 
        voluntary cooperation of ordinary citizens is a critical 
        component.
            (5) Voluntary cooperation is difficult for law enforcement 
        officials to obtain when citizens feel that cooperation carries 
        the risk of violent retaliation by illegal drug trafficking 
        organizations and their affiliates.
            (6) Public confidence that law enforcement is doing all it 
        can to make communities safe is a prerequisite for voluntary 
        cooperation among people who may be subject to intimidation or 
        reprisal (or both).
            (7) Witness protection programs are insufficient on their 
        own to provide security because many individuals and families 
        who strive every day to make distressed neighborhoods livable 
        for their children, other relatives, and neighbors will resist 
        or refuse offers of relocation by local, State, and Federal 
        prosecutorial agencies and because, moreover, the continued 
        presence of strong individuals and families is critical to 
        preserving and strengthening the social fabric in such 
        communities.
            (8) Where (as in certain sections of Baltimore City) 
        interstate trafficking of illegal drugs has severe ancillary 
        local consequences within areas designated as high intensity 
        drug trafficking areas, it is important that supplementary High 
        Intensity Drug Trafficking Areas Program funds be committed to 
        support initiatives aimed at making the affected communities 
        safe for the residents of those communities and encouraging 
        their cooperation with tribal, local, State, and Federal law 
        enforcement efforts to combat illegal drug trafficking.
    (c) Funding for Certain High Intensity Drug Trafficking Areas.--
Section 707, as amended by section 301, is amended by adding at the end 
the following:
    ``(q) Specific Purposes.--
            ``(1) In general.--The Director shall ensure that, of the 
        amounts appropriated for a fiscal year for the Program, at 
        least $7,000,000 is used in high intensity drug trafficking 
        areas with severe neighborhood safety and illegal drug 
        distribution problems.
            ``(2) Required uses.--The funds used under paragraph (1) 
        shall be used--
                    ``(A) to ensure the safety of neighborhoods and the 
                protection of communities, including the prevention of 
                the intimidation of potential witnesses of illegal drug 
                distribution and related activities; and
                    ``(B) to combat illegal drug trafficking through 
                such methods as the Director considers appropriate, 
                such as establishing or operating (or both) a toll-free 
                telephone hotline for use by the public to provide 
                information about illegal drug-related activities.''.

SEC. 303. ASSESSMENT.

    The Director shall assess the ability of the HIDTA Program to 
respond to the so-called ``balloon effect'', whereby urban drug 
traffickers facing intensive law enforcement efforts expand and spread 
their trafficking and distribution into rural, suburban, and smaller 
urban areas by conducting a demonstration project examining the ability 
of the New York/New Jersey HIDTA, with its new single colocated 
Organized Crime and Drug Enforcement Task Force/High Intensity Drug 
Trafficking Area Strike Force and HIDTA Regional Intelligence Center, 
to address the movement of drug traffickers into the more rural, 
suburban, and smaller areas encompassed by the counties of Albany, 
Onondaga, Monroe, and Erie in New York State and by annexing these 
counties into the existing New York/New Jersey HIDTA.

                          TITLE IV--TECHNOLOGY

SEC. 401. COUNTERDRUG TECHNOLOGY ASSESSMENT CENTER.

    (a) Chief Scientist.--Section 708(b) is amended to read as follows:
    ``(b) Chief Scientist.--There shall be at the head of the Center 
the Chief Scientist, who shall be appointed by the Director from among 
individuals qualified and distinguished in the area of science, 
medicine, engineering, or technology.''.
    (b) Responsibilities.--
            (1) Research and development.--Section 708 is amended by--
                    (A) redesignating subsection (d) as subsection (e); 
                and
                    (B) striking subsection (c) and inserting the 
                following:
    ``(c) Research and Development Responsibilities.--The Director, 
acting through the Chief Scientist, shall--
            ``(1) identify and define the short-, medium-, and long-
        term scientific and technological needs of Federal, State, 
        local, and tribal drug supply reduction agencies, including--
                    ``(A) advanced surveillance, tracking, and radar 
                imaging;
                    ``(B) electronic support measures;
                    ``(C) communications;
                    ``(D) data fusion, advanced computer systems, and 
                artificial intelligence; and
                    ``(E) chemical, biological, radiological (including 
                neutron and electron), and other means of detection;
            ``(2) identify demand reduction basic and applied research 
        needs and initiatives, in consultation with affected National 
        Drug Control Program agencies, including--
                    ``(A) improving treatment through neuroscientific 
                advances;
                    ``(B) improving the transfer of biomedical research 
                to the clinical setting; and
                    ``(C) in consultation with the National Institute 
                of Drug Abuse and the Substance Abuse and Mental Health 
                Services Administration, and through interagency 
                agreements or grants, examining addiction and 
                rehabilitation research and the application of 
                technology to expanding the effectiveness and 
                availability of drug treatment;
            ``(3) make a priority ranking of such needs identified in 
        paragraphs (1) and (2) according to fiscal and technological 
        feasibility, as part of a National Counterdrug Research and 
        Development Program;
            ``(4) oversee and coordinate counterdrug technology 
        initiatives with related activities of other Federal civilian 
        and military departments;
            ``(5) provide support to the development and implementation 
        of the national drug control performance measurement system 
        established under subsection (c) of section 706; and
            ``(6) pursuant to the authority of the Director of National 
        Drug Control Policy under section 704, submit requests to 
        Congress for the reprogramming or transfer of funds 
        appropriated for counterdrug technology research and 
        development.
    ``(d) Limitation on Authority.--The authority granted to the 
Director under this section shall not extend to the awarding of 
contracts, management of individual projects, or other operational 
activities.''.
            (2) Assistance and support.--Subsection (e) of section 708, 
        as redesignated by this section, is amended to read as follows:
    ``(e) Assistance and Support to the Office of National Drug Control 
Policy.--The Secretary of Defense, the Secretary of Homeland Security, 
and the Secretary of Health and Human Services shall, to the maximum 
extent practicable, render assistance and support to the Office and to 
the Director in the conduct of counterdrug technology assessment.''.
            (3) Technology transfer program.--Section 708 is amended by 
        adding at the end the following:
    ``(f) Technology Transfer Program.--
            ``(1) Program.--The Chief Scientist, with the advice and 
        counsel of experts from State, local, and tribal law 
        enforcement agencies, shall be responsible to the Director for 
        coordination and implementation of a counterdrug technology 
        transfer program.
            ``(2) Purpose.--The purpose of the Technology Transfer 
        Program shall be for the Counterdrug Technology Assessment 
        Center to transfer technology and associated training directly 
        to State, local, and tribal law enforcement agencies.
            ``(3) Priority of receipts.--Transfers shall be made in 
        priority order based on--
                    ``(A) the need of potential recipients for such 
                technology;
                    ``(B) the effectiveness of the technology to 
                enhance current counterdrug activities of potential 
                recipients; and
                    ``(C) the ability and willingness of potential 
                recipients to evaluate transferred technology.
            ``(4) Agreement authority.--The Director may enter into an 
        agreement with the Secretary of Homeland Security to transfer 
        technology with both counterdrug and homeland security 
        applications to State, local, and tribal law enforcement 
        agencies on a reimbursable basis.
            ``(5) Report.--On or before July 1 of each year, the 
        Director shall submit a report to the appropriate congressional 
        committees that addresses the following:
                    ``(A) The number of requests received during the 
                previous 12 months, including the identity of each 
                requesting agency and the type of technology requested.
                    ``(B) The number of requests fulfilled during the 
                previous 12 months, including the identity of each 
                recipient agency and the type of technology 
                transferred.
                    ``(C) A summary of the criteria used in making the 
                determination on what requests were funded and what 
                requests were not funded, except that such summary 
                shall not include specific information on any 
                individual requests.
                    ``(D) A general assessment of the future needs of 
                the program, based on expected changes in threats, 
                expected technologies, and likely need from potential 
                recipients.
                    ``(E) An assessment of the effectiveness of the 
                technologies transferred, based in part on the 
                evaluations provided by the recipients, with a 
                recommendation whether the technology should continue 
                to be offered through the program.''.
    (c) Assistance From Secretary of Homeland Security.--Section 708(d) 
(21 U.S.C. 1707(d)) is amended by inserting ``, the Secretary of 
Homeland Security,'' after ``The Secretary of Defense''.

                 TITLE V--NATIONAL YOUTH MEDIA CAMPAIGN

SEC. 501. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN.

    (a) In General.--Section 709 (21 U.S.C. 1708) is amended to read as 
follows:

``SEC. 709. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN.

    ``(a) In General.--The Director shall conduct a national youth 
anti-drug media campaign (referred to in this subtitle as the `national 
media campaign') in accordance with this section for the purposes of--
            ``(1) preventing drug abuse among young people in the 
        United States;
            ``(2) increasing awareness of adults of the impact of drug 
        abuse on young people; and
            ``(3) encouraging parents and other interested adults to 
        discuss with young people the dangers of illegal drug use.
    ``(b) Use of Funds.--
            ``(1) In general.--Amounts made available to carry out this 
        section for the national media campaign may only be used for 
        the following:
                    ``(A) The purchase of media time and space, 
                including the strategic planning for, and accounting 
                of, such purchases.
                    ``(B) Creative and talent costs, consistent with 
                paragraph (2)(A).
                    ``(C) Advertising production costs.
                    ``(D) Testing and evaluation of advertising.
                    ``(E) Evaluation of the effectiveness of the 
                national media campaign.
                    ``(F) The negotiated fees for the winning bidder on 
                requests for proposals issued either by the Office or 
                its designee to enter into contracts to carry out 
                activities authorized by this section.
                    ``(G) Partnerships with professional and civic 
                groups, community-based organizations, including faith-
                based organizations, and government organizations 
                related to the national media campaign.
                    ``(H) Entertainment industry outreach, interactive 
                outreach, media projects and activities, public 
                information, news media outreach, and corporate 
                sponsorship and participation.
                    ``(I) Operational and management expenses.
            ``(2) Specific requirements.--
                    ``(A) Creative services.--
                            ``(i) In using amounts for creative and 
                        talent costs under paragraph (1)(B), the 
                        Director shall use creative services donated at 
                        no cost to the Government (including creative 
                        services provided by the Partnership for a 
                        Drug-Free America) wherever feasible and may 
                        only procure creative services for 
                        advertising--
                                    ``(I) responding to high-priority 
                                or emergent campaign needs that cannot 
                                timely be obtained at no cost; or
                                    ``(II) intended to reach a 
                                minority, ethnic, or other special 
                                audience that cannot reasonably be 
                                obtained at no cost; or
                                    ``(III) the Director determines 
                                that the Partnership for a Drug-Free 
                                America is unable to provide, pursuant 
                                to subsection (d)(2)(B).
                            ``(ii) Subject to the availability of 
                        appropriations, no more than $1,500,000 may be 
                        expended under this section each fiscal year on 
                        creative services, except that the Director may 
                        expend up to $2,000,000 in a fiscal year on 
                        creative services to meet urgent needs of the 
                        national media campaign with advance approval 
                        from the Committee on Appropriations of the 
                        Senate and of the House of Representatives upon 
                        a showing of the circumstances causing such 
                        urgent needs of the national media campaign.
                    ``(B) Testing and evaluation of advertising.--In 
                using amounts for testing and evaluation of advertising 
                under paragraph (1)(D), the Director shall test all 
                advertisements prior to use in the national media 
                campaign to ensure that the advertisements are 
                effective and meet industry-accepted standards. The 
                Director may waive this requirement for advertisements 
                using no more than 10 percent of the purchase of 
                advertising time purchased under this section in a 
                fiscal year and no more than 10 percent of the 
                advertising space purchased under this section in a 
                fiscal year, if the advertisements respond to emergent 
                and time-sensitive campaign needs or the advertisements 
                will not be widely utilized in the national media 
                campaign.
                    ``(C) Evaluation of effectiveness of media 
                campaign.--In using amounts for the evaluation of the 
                effectiveness of the national media campaign under 
                paragraph (1)(E), the Director shall--
                            ``(i) designate an independent entity to 
                        evaluate by April 20 of each year the 
                        effectiveness of the national media campaign 
                        based on data from--
                                    ``(I) the Monitoring the Future 
                                Study published by the Department of 
                                Health and Human Services;
                                    ``(II) the Attitude Tracking Study 
                                published by the Partnership for a 
                                Drug-Free America;
                                    ``(III) the National Household 
                                Survey on Drug Abuse; and
                                    ``(IV) other relevant studies or 
                                publications, as determined by the 
                                Director, including tracking and 
                                evaluation data collected according to 
                                marketing and advertising industry 
                                standards; and
                            ``(ii) ensure that the effectiveness of the 
                        national media campaign is evaluated in a 
                        manner that enables consideration of whether 
                        the national media campaign has contributed to 
                        reduction of illicit drug use among youth and 
                        such other measures of evaluation as the 
                        Director determines are appropriate.
            ``(3) Purchase of advertising time and space.--Subject to 
        the availability of appropriations, for each fiscal year, not 
        less than 77 percent of the amounts appropriated under this 
        section shall be used for the purchase of advertising time and 
        space for the national media campaign, subject to the following 
        exceptions:
                    ``(A) In any fiscal year for which less than 
                $125,000,000 is appropriated for the national media 
                campaign, not less than 72 percent of the amounts 
                appropriated under this section shall be used for the 
                purchase of advertising time and space for the national 
                media campaign.
                    ``(B) In any fiscal year for which more than 
                $195,000,000 is appropriated under this section, not 
                less than 82 percent shall be used for advertising 
                production costs and the purchase of advertising time 
                and space for the national media campaign.
    ``(c) Advertising.--In carrying out this section, the Director 
shall ensure that sufficient funds are allocated to meet the stated 
goals of the national media campaign.
    ``(d) Division of Responsibilities and Functions Under the 
Program.--
            ``(1) In general.--The Director, in consultation with the 
        Partnership for a Drug-Free America, shall determine the 
        overall purposes and strategy of the national media campaign.
            ``(2) Responsibilities.--
                    ``(A) Director.--The Director shall be responsible 
                for implementing a focused national media campaign to 
                meet the purposes set forth in subsection (a), and 
                shall approve--
                            ``(i) the strategy of the national media 
                        campaign;
                            ``(ii) all advertising and promotional 
                        material used in the national media campaign; 
                        and
                            ``(iii) the plan for the purchase of 
                        advertising time and space for the national 
                        media campaign.
                    ``(B) The partnership for a drug-free america.--The 
                Director shall request that the Partnership for a Drug-
                Free America--
                            ``(i) develop and recommend strategies to 
                        achieve the goals of the national media 
                        campaign, including addressing national and 
                        local drug threats in specific regions or 
                        States, such as methamphetamine and ecstasy;
                            ``(ii) create all advertising to be used in 
                        the national media campaign, except 
                        advertisements that are--
                                    ``(I) provided by other nonprofit 
                                entities pursuant to subsection (f);
                                    ``(II) intended to respond to high-
                                priority or emergent campaign needs 
                                that cannot timely be obtained at no 
                                cost (not including production costs 
                                and talent reuse payments), provided 
                                that any such advertising material is 
                                reviewed by the Partnership for a Drug-
                                Free America;
                                    ``(III) intended to reach a 
                                minority, ethnic, or other special 
                                audience that cannot be obtained at no 
                                cost (not including production costs 
                                and talent reuse payments), provided 
                                that any such advertising material is 
                                reviewed by the Partnership for a Drug-
                                Free America; or
                                    ``(IV) any other advertisements 
                                that the Director determines that the 
                                Partnership for a Drug-Free America is 
                                unable to provide or if the Director 
                                determines that another entity is more 
                                appropriate, subject to the 
                                requirements of subsection (b)(2)(A) .
                If the Director determines that another entity is more 
                appropriate under clause (ii)(IV), the Director shall 
                notify Congress, through the committees of jurisdiction 
                in the House and Senate, in writing, not less than 30 
                days prior to contracting with a party other than the 
                Partnership for a Drug-Free America .
                    ``(C) Media buying contractor.--The Director shall 
                enter into a contract with a media buying contractor to 
                plan and purchase advertising time and space for the 
                national media campaign. The media buying contractor 
                shall not provide any other service or material, or 
                conduct any other function or activity which the 
                Director determines should be provided by the 
                Partnership for a Drug-Free America.
    ``(e) Prohibitions.--None of the amounts made available under 
subsection (b) may be obligated or expended for any of the following:
            ``(1) To supplant current anti-drug community-based 
        coalitions.
            ``(2) To supplant pro bono public service time donated by 
        national and local broadcasting networks for other public 
        service campaigns.
            ``(3) For partisan political purposes, or express advocacy 
        in support of or to defeat any clearly identified candidate, 
        clearly identified ballot initiative, or clearly identified 
        legislative or regulatory proposal.
            ``(4) To fund advertising that features any elected 
        officials, persons seeking elected office, cabinet level 
        officials, or other Federal officials employed pursuant to 
        section 213 of Schedule C of title 5, Code of Federal 
        Regulations.
            ``(5) To fund advertising that does not contain a primary 
        message intended to reduce or prevent illicit drug use.
            ``(6) To fund advertising containing a primary message 
        intended to promote support for the media campaign or private 
        sector contributions to the media campaign.
    ``(f) Matching Requirement.--
            ``(1) In general.--Amounts made available under subsection 
        (b) for media time and space shall be matched by an equal 
        amount of non-Federal funds for the national media campaign, or 
        be matched with in-kind contributions of the same value.
            ``(2) No-cost match advertising direct relationship 
        requirement.--The Director shall ensure that at least 70 
        percent of no-cost match advertising provided directly relates 
        to substance abuse prevention consistent with the specific 
        purposes of the national media campaign, except that in any 
        fiscal year in which less than $125,000,000 is appropriated to 
        the national media campaign, the Director shall ensure that at 
        least 85 percent of no-cost match advertising directly relates 
        to substance abuse prevention consistent with the specific 
        purposes of the national media campaign.
            ``(3) No-cost match advertising not directly related.--The 
        Director shall ensure that no-cost match advertising that does 
        not directly relate to substance abuse prevention consistent 
        with the purposes of the national media campaign includes a 
        clear anti-drug message. Such message is not required to be the 
        primary message of the match advertising.
    ``(g) Financial and Performance Accountability.--The Director shall 
cause to be performed--
            ``(1) audits and reviews of costs of the national media 
        campaign pursuant to section 304C of the Federal Property and 
        Administrative Services Act of 1949 (41 U.S.C. 254d); and
            ``(2) an audit to determine whether the costs of the 
        national media campaign are allowable under section 306 of such 
        Act (41 U.S.C. 256).
    ``(h) Report to Congress.--The Director shall submit on an annual 
basis a report to Congress that describes--
            ``(1) the strategy of the national media campaign and 
        whether specific objectives of the media campaign were 
        accomplished;
            ``(2) steps taken to ensure that the national media 
        campaign operates in an effective and efficient manner 
        consistent with the overall strategy and focus of the national 
        media campaign;
            ``(3) plans to purchase advertising time and space;
            ``(4) policies and practices implemented to ensure that 
        Federal funds are used responsibly to purchase advertising time 
        and space and eliminate the potential for waste, fraud, and 
        abuse; and
            ``(5) all contracts entered into with a corporation, 
        partnership, or individual working on behalf of the national 
        media campaign.
    ``(i) Local Target Requirement.--The Director shall, to the maximum 
extent feasible, use amounts made available under this section for 
media that focuses on, or includes specific information on, prevention 
or treatment resources for consumers within specific local areas.
    ``(j) Prevention of Marijuana Use.--
            ``(1) Findings.--The Congress finds the following:
                    ``(A) 60 percent of adolescent admissions for drug 
                treatment are based on marijuana use.
                    ``(B) Potency levels of contemporary marijuana, 
                particularly hydroponically grown marijuana, are 
                significantly higher than in the past, rising from 
                under 1 percent of THC in the mid-1970s to as high as 
                30 percent today.
                    ``(C) Contemporary research has demonstrated that 
                youths smoking marijuana early in life may be up to 5 
                times more likely to use hard drugs.
                    ``(D) Contemporary research has demonstrated clear 
                detrimental effects in adolescent educational 
                achievement resulting from marijuana use.
                    ``(E) Contemporary research has demonstrated clear 
                detrimental effects in adolescent brain development 
                resulting from marijuana use.
                    ``(F) An estimated 9,000,000 Americans a year drive 
                while under the influence of illegal drugs, including 
                marijuana.
                    ``(G) Marijuana smoke contains 50 to 70 percent 
                more of certain cancer causing chemicals than tobacco 
                smoke.
                    ``(H) Teens who use marijuana are up to 4 times 
                more likely to have a teen pregnancy than teens who 
                have not.
                    ``(I) Federal law enforcement agencies have 
                identified clear links suggesting that trade in 
                hydroponic marijuana facilitates trade by criminal 
                organizations in hard drugs, including heroin.
                    ``(J) Federal law enforcement agencies have 
                identified possible links between trade in cannabis 
                products and financing for terrorist organizations.
            ``(2) Emphasis on prevention of youth marijuana use.--In 
        conducting advertising and activities otherwise authorized 
        under this section, the Director may emphasize prevention of 
        youth marijuana use.
    ``(k) Prevention of Methamphetamine Abuse and Other Emerging Drug 
Abuse Threats.--
            ``(1) Requirement to use 10 percent of funds for 
        methamphetamine abuse prevention.--The Director shall ensure 
        that, of the amounts appropriated under this section for the 
        national media campaign for a fiscal year, not less than 10 
        percent shall be expended solely for the activities described 
        subsection (b)(1) with respect to advertisements specifically 
        intended to reduce the use of methamphetamine.
            ``(2) Authority to use funds for other drug abuse upon 
        certification that methamphetamine abuse fell during fiscal 
        year 2007.--With respect to fiscal year 2008 and any fiscal 
        year thereafter, if the Director certifies in writing to 
        Congress that domestic methamphetamine laboratory seizures (as 
        reported to the El Paso Intelligence Center of the Drug 
        Enforcement Administration) decreased to at least 75 percent of 
        the 2006 level, or the Director has documented a highly, 
        statistically significant increase in a specific drug, from a 
        baseline determined by locally collected data, that can be 
        defined as a local drug crisis, the Director may apply 
        paragraph (1)(A) for that fiscal year with respect to 
        advertisements specifically intended to reduce the use of such 
        other drugs.
    ``(l) Authorization of Appropriations.--There is authorized to be 
appropriated to the Office to carry out this section, $195,000,000 for 
each of fiscal years 2007 and 2008 and $210,000,000 for each of fiscal 
years 2009 through 2011.''.
    (b) Repeal of Superseded Provisions.--The Drug-Free Media Campaign 
Act of 1998 (21 U.S.C. 1801 et seq.) is repealed.

       TITLE VI--AUTHORIZATIONS AND EXTENSION OF TERMINATION DATE

SEC. 601. AUTHORIZATION OF APPROPRIATIONS.

    Section 714 is amended--
            (1) by striking ``title,'' and inserting ``title except 
        activities otherwise specified,''; and
            (2) by striking ``1999 through 2003'' and inserting ``2006 
        through 2010''.

SEC. 602. EXTENSION OF TERMINATION DATE.

    Section 715(a) is amended by striking ``September 30, 2003, this 
title and the amendments made by this title'' and inserting ``September 
30, 2010, this title and the amendments made to this title''.

                     TITLE VII--ANTI-DOPING AGENCY

SEC. 701. DESIGNATION OF UNITED STATES ANTI-DOPING AGENCY.

    (a) Definitions.--In this title:
            (1) United states olympic committee.--The term ``United 
        States Olympic Committee'' means the organization established 
        by the ``Ted Stevens Olympic and Amateur Sports Act'' (36 
        U.S.C. 220501 et seq.).
            (2) Amateur athletic competition.--The term ``amateur 
        athletic competition'' means a contest, game, meet, match, 
        tournament, regatta, or other event in which amateur athletes 
        compete (36 U.S.C. 220501(b)(2)).
            (3) Amateur athlete.--The term ``amateur athlete'' means an 
        athlete who meets the eligibility standards established by the 
        national governing body or paralympic sports organization for 
        the sport in which the athlete competes (36 U.S.C. 
        22501(b)(1)).
            (4) Gene doping.--The term ``gene doping'' means the 
        nontherapeutic use of cells, genes, genetic elements, or of the 
        modulation of gene expression, having the capacity to enhance 
        athletic performance.
    (b) In General.--The United States Anti-Doping Agency shall--
            (1) serve as the independent anti-doping organization for 
        the amateur athletic competitions recognized by the United 
        States Olympic Committee;
            (2) ensure that athletes participating in amateur athletic 
        activities recognized by the United States Olympic Committee 
        are prevented from using performance-enhancing drugs, or 
        performance-enhancing genetic modifications accomplished 
        through gene-doping;
            (3) implement anti-doping education, research, testing, and 
        adjudication programs to prevent United States Amateur Athletes 
        participating in any activity recognized by the United States 
        Olympic Committee from using performance-enhancing drugs, or 
        performance-enhancing genetic modifications accomplished 
        through gene-doping;
            (4) serve as the United States representative responsible 
        for coordination with other anti-doping organizations 
        coordinating amateur athletic competitions recognized by the 
        United States Olympic Committee to ensure the integrity of 
        athletic competition, the health of the athletes and the 
        prevention of use of performance-enhancing drugs, or 
        performance-enhancing genetic modifications accomplished 
        through gene-doping by United States amateur athletes; and
            (5) permanently include ``gene doping'' among any list of 
        prohibited substances adopted by the Agency.

SEC. 702. RECORDS, AUDIT, AND REPORT.

    (a) Records.--The United States Anti-Doping Agency shall keep 
correct and complete records of account.
    (b) Report.--The United States Anti-Doping Agency shall submit an 
annual report to Congress which shall include--
            (1) an audit conducted and submitted in accordance with 
        section 10101 of title 36, United States Code; and
            (2) a description of the activities of the agency.

SEC. 703. AUTHORIZATION OF APPROPRIATIONS.

    There are authorized to be appropriated to the United States Anti-
Doping Agency--
            (1) for fiscal year 2007, $9,700,000;
            (2) for fiscal year 2008, $10,300,000;
            (3) for fiscal year 2009, $10,600,000;
            (4) for fiscal year 2010, $11,000,000; and
            (5) for fiscal year 2011, $11,500,000.

                   TITLE VIII--DRUG-FREE COMMUNITIES

SEC. 801. REAUTHORIZATION.

    (a) In General.--Section 1024(a) of the Drug-Free Communities Act 
of 1997 (21 U.S.C. 1524(a)) is amended--
            (1) in paragraph (9), by striking ``and'' after the 
        semicolon;
            (2) in paragraph (10), by striking the period and inserting 
        a semicolon; and
            (3) by adding at the end the following:
            ``(11) $109,000,000 for fiscal year 2008;
            ``(12) $114,000,000 for fiscal year 2009;
            ``(13) $119,000,000 for fiscal year 2010;
            ``(14) $124,000,000 for fiscal year 2011; and
            ``(15) $129,000,000 for fiscal year 2012.''.
    (b) Administration Costs.--Section 1024(b) of the Drug-Free 
Communities Act of 1997 (21 U.S.C. 1524(b)) is amended to read as 
follows:
    ``(b) Administrative Costs.--
            ``(1) Limitation.--Not more than 3 percent of the funds 
        appropriated for this chapter may be used by the Office of 
        National Control Policy to pay for administrative costs 
        associated with their responsibilities under the chapter.
            ``(2) Designated agency.--The agency delegated to carry out 
        this program under section 1031(d) may use up to 5 percent of 
        the funds allocated for grants under this chapter for 
        administrative costs associated with carrying out the 
        program.''.

SEC. 802. SUSPENSION OF GRANTS.

    (a) In General.--Section 1032(b) of the Drug-Free Communities Act 
of 1997 (21 U.S.C. 1532(b)) is amended by adding at the end the 
following:
            ``(4) Process for suspension.--A grantee shall not be 
        suspended or terminated under paragraph (1)(A)(ii), 
        (2)(A)(iii), or (3)(E) unless that grantee is afforded a fair, 
        timely, and independent appeal prior to such suspension or 
        termination.''.
    (b) Report to Congress.--Not later than 60 days after the date of 
enactment of this Act, the Director of the Office of National Drug 
Control Policy shall submit to Congress a report detailing the appeals 
process required by section 1032(b)(4) of the Drug-Free Communities Act 
of 1997, as added by subsection (a).

SEC. 803. GRANT AWARD INCREASE.

    Subsections (b)(1)(A)(iv), (b)(2)(C)(i), and (b)(3)(F) of section 
1032 of the Drug-Free Communities Act of 1997 (21 U.S.C. 1532) are 
amended by striking ``$100,000'' and inserting ``$125,000''.

SEC. 804. PROHIBITION ON ADDITIONAL ELIGIBILITY CRITERIA.

    Section 1032(a) of the Drug-Free Communities Act of 1997 (21 U.S.C. 
1532(a)) is amended by adding at the end the following:
            ``(7) Additional criteria.--The Director shall not impose 
        any eligibility criteria on new applicants or renewal grantees 
        not provided in this chapter.''.

SEC. 805. NATIONAL COMMUNITY ANTI-DRUG COALITION INSTITUTE.

    Section 4 of Public Law 107-82 (21 U.S.C. 1521 note), reauthorizing 
the Drug-Free Communities Support Program, is amended--
            (1) by amending subsection (a) to read as follows:
    ``(a) In General.--The Director of the Office of National Drug 
Control Policy shall, using amounts authorized to be appropriated by 
subsection (d), make a directed grant to Community Anti-Drug Coalitions 
of America to provide for the continuation of the National Community 
Anti-drug Coalition Institute.'';
            (2) by striking subsection (b) and redesignating 
        subsections (c) and (d) as (b) and (c), respectively; and
            (3) in subsection (c), as redesignated by paragraph (2), by 
        adding at the end the following:
            ``(4) For each of the fiscal years 2008 through 2012, 
        $2,000,000.''.

              TITLE IX--NATIONAL GUARD COUNTERDRUG SCHOOLS

SEC. 901. NATIONAL GUARD COUNTERDRUG SCHOOLS.

    (a) Authority To Operate.--Under such regulations as the Secretary 
of Defense may prescribe, the Chief of the National Guard Bureau may 
establish and operate, or provide financial assistance to the States to 
establish and operate, not more than 5 schools (to be known generally 
as ``National Guard counterdrug schools'').
    (b) Purpose.--The purpose of the National Guard counterdrug schools 
shall be the provision by the National Guard of training in drug 
interdiction and counterdrug activities and drug demand reduction 
activities to personnel of the following:
            (1) Federal agencies.
            (2) State, local, and tribal law enforcement agencies.
            (3) Community-based organizations engaged in such 
        activities.
            (4) Other non-Federal governmental and private entities and 
        organizations engaged in such activities.
    (c) Counterdrug Schools Specified.--The National Guard counterdrug 
schools operated under the authority in subsection (a) are as follows:
            (1) The National Interagency Civil-Military Institute 
        (NICI), San Luis Obispo, California.
            (2) The Multi-Jurisdictional Counterdrug Task Force 
        Training (MCTFT), St. Petersburg, Florida.
            (3) The Midwest Counterdrug Training Center (MCTC), 
        Johnston, Iowa.
            (4) The Regional Counterdrug Training Academy (RCTA), 
        Meridian, Mississippi.
            (5) The Northeast Regional Counterdrug Training Center 
        (NCTC), Fort Indiantown Gap, Pennsylvania.
    (d) Use of National Guard Personnel.--
            (1) In general.--To the extent provided for in the State 
        drug interdiction and counterdrug activities plan of a State in 
        which a National Guard counterdrug school is located, personnel 
        of the National Guard of that State who are ordered to perform 
        full-time National Guard duty authorized under section 112(b) 
        of that title 32, United States Code, may provide training 
        referred to in subsection (b) at that school.
            (2) Definition.--In this subsection, the term ``State drug 
        interdiction and counterdrug activities plan'', in the case of 
        a State, means the current plan submitted by the Governor of 
        the State to the Secretary of Defense under section 112 of 
        title 32, United States Code.
    (e) Treatment Under Authority To Provide Counterdrug Support.--The 
provisions of section 1004 of the National Defense Authorization Act 
for Fiscal Year 1991 (Public Law 101-510; 10 U.S.C. 374 note) shall 
apply to any activities of a National Guard counterdrug school under 
this section that are for an agency referred to in subsection (a) of 
such section 1004 and for a purpose set forth in subsection (b) of such 
section 1004.
    (f) Annual Reports on Activities.--
            (1) In general.--Not later than February 1 each year, the 
        Secretary of Defense shall submit to Congress a report on the 
        activities of the National Guard counterdrug schools during the 
        preceding year.
            (2) Contents.--Each report under paragraph (1) shall set 
        forth the following:
                    (A) Funding.--The amount made available for each 
                National Guard counterdrug school during the fiscal 
                year ending in the year preceding the year in which 
                such report is submitted.
                    (B) Activities.--A description of the activities of 
                each National Guard counterdrug school during the year 
                preceding the year in which such report is submitted.
    (g) Authorization of Appropriations.--
            (1) In general.--There is hereby authorized to be 
        appropriated for the Department of Defense for the National 
        Guard for each of fiscal years 2006 through 2010, $30,000,000 
        for purposes of the National Guard counterdrug schools in such 
        fiscal year.
            (2) Construction.--The amount authorized to be appropriated 
        by paragraph (1) for a fiscal year is in addition to any other 
        amount authorized to be appropriated for the Department of 
        Defense for the National Guard for such fiscal year.

TITLE X--NATIONAL METHAMPHETAMINE INFORMATION CLEARINGHOUSE ACT OF 2006

SEC. 1001. SHORT TITLE.

    This title may be cited as the ``National Methamphetamine 
Information Clearinghouse Act of 2006''.

SEC. 1002. DEFINITIONS.

    In this title--
            (1) the term ``Council'' means the National Methamphetamine 
        Advisory Council established under section 1003(b)(1);
            (2) the term ``drug endangered children'' means children 
        whose physical, mental, or emotional health are at risk because 
        of the production, use, or other effects of methamphetamine 
        production or use by another person;
            (3) the term ``National Methamphetamine Information 
        Clearinghouse'' or ``NMIC'' means the information clearinghouse 
        established under section 1003(a); and
            (4) the term ``qualified entity'' means a State, local, or 
        tribal government, school board, or public health, law 
        enforcement, nonprofit, community anti-drug coalition, or other 
        nongovernmental organization providing services related to 
        methamphetamines.

SEC. 1003. ESTABLISHMENT OF CLEARINGHOUSE AND ADVISORY COUNCIL.

    (a) Clearinghouse.--There is established, under the supervision of 
the Attorney General of the United States, an information clearinghouse 
to be known as the National Methamphetamine Information Clearinghouse.
    (b) Advisory Council.--
            (1) In general.--There is established an advisory council 
        to be known as the National Methamphetamine Advisory Council.
            (2) Membership.--The Council shall consist of 10 members 
        appointed by the Attorney General--
                    (A) not fewer than 3 of whom shall be 
                representatives of law enforcement agencies;
                    (B) not fewer than 4 of whom shall be 
                representatives of nongovernmental and nonprofit 
                organizations providing services or training and 
                implementing programs or strategies related to 
                methamphetamines; and
                    (C) 1 of whom shall be a representative of the 
                Department of Health and Human Services.
            (3) Period of appointment; vacancies.--Members shall be 
        appointed for 3 years. Any vacancy in the Council shall not 
        affect its powers, but shall be filled in the same manner as 
        the original appointment.
            (4) Personnel matters.--
                    (A) Travel expenses.--The members of the Council 
                shall be allowed travel expenses, including per diem in 
                lieu of subsistence, at rates authorized for employees 
                of agencies under subchapter I of chapter 57 of title 
                5, United States Code, while away from their homes or 
                regular places of business in the performance of 
                services for the Council.
                    (B) No compensation.--The members of the Council 
                shall not receive compensation for the performance of 
                the duties of a member of the Council.

SEC. 1004. NMIC REQUIREMENTS AND REVIEW.

    (a) In General.--The NMIC shall promote sharing information 
regarding successful law enforcement, treatment, environmental, 
prevention, social services, and other programs related to the 
production, use, or effects of methamphetamine and grants available for 
such programs.
    (b) Components.--The NMIC shall include--
            (1) a toll-free number; and
            (2) a website that provides a searchable database, which--
                    (A) provides information on the short-term and 
                long-term effects of methamphetamine use;
                    (B) provides information regarding methamphetamine 
                treatment and prevention programs and strategies and 
                programs for drug endangered children, including 
                descriptions of successful programs and strategies and 
                contact information for such programs and strategies;
                    (C) provides information regarding grants for 
                methamphetamine-related programs, including contact 
                information and links to websites;
                    (D) allows a qualified entity to submit items to be 
                posted on the website regarding successful public or 
                private programs or other useful information related to 
                the production, use, or effects of methamphetamine;
                    (E) includes a restricted section that may only be 
                accessed by a law enforcement organization that 
                contains successful strategies, training techniques, 
                and other information that the Council determines 
                helpful to law enforcement agency efforts to identify 
                or combat the production, use or effects of 
                methamphetamine;
                    (F) allows public access to all information not in 
                a restricted section; and
                    (G) contains any additional information the Council 
                determines may be useful in identifying or combating 
                the production, use, or effects of methamphetamine.
Thirty days after the website in paragraph (2) is operational, no funds 
shall be expended to continue the website methresources.gov.
    (c) Review of Posted Information.--
            (1) In general.--Not later than 30 days after the date of 
        submission of an item by a qualified entity, the Council shall 
        review an item submitted for posting on the website described 
        in subsection (b)(2)--
                    (A) to evaluate and determine whether the item, as 
                submitted or as modified, meets the requirements for 
                posting; and
                    (B) in consultation with the Attorney General, to 
                determine whether the item should be posted in a 
                restricted section of the website.
            (2) Determination.--Not later than 45 days after the date 
        of submission of an item, the Council shall--
                    (A) post the item on the website described in 
                subsection (b)(2); or
                    (B) notify the qualified entity that submitted the 
                item regarding the reason such item shall not be posted 
                and modifications, if any, that the qualified entity 
                may make to allow the item to be posted.

SEC. 1005. AUTHORIZATION OF APPROPRIATIONS.

    There are authorized to be appropriated--
            (1) for fiscal year 2007--
                    (A) $500,000 to establish the NMIC and Council; and
                    (B) such sums as are necessary for the operation of 
                the NMIC and Council; and
            (2) for each of fiscal years 2008 and 2009, such sums as 
        are necessary for the operation of the NMIC and Council.

                   TITLE XI--MISCELLANEOUS PROVISIONS

SEC. 1101. REPEALS.

    (a) Act.--Section 710 is repealed.
    (b) Forfeiture Assets.--Section 6073 of the Assets Forfeiture 
Amendments Act of 1988 (21 U.S.C. 1509) is repealed.

SEC. 1102. CONTROLLED SUBSTANCES ACT AMENDMENTS.

    Section 303(g)(2) of the Controlled Substances Act (21 U.S.C. 
823(g)(2)) is amended--
            (1) in subparagraph (B)(iii), by striking ``except that 
        the'' and inserting the following: ``unless, not sooner than 1 
        year after the date on which the practitioner submitted the 
        initial notification, the practitioner submits a second 
        notification to the Secretary of the need and intent of the 
        practitioner to treat up to 100 patients. A second notification 
        under this clause shall contain the certifications required by 
        clauses (i) and (ii) of this subparagraph. The''; and
            (2) in subparagraph (J)--
                    (A) in clause (i), by striking ``thereafter'' and 
                all that follows through the period and inserting 
                ``thereafter.'';
                    (B) in clause (ii), by striking ``Drug Addiction 
                Treatment Act of 2000'' and inserting ``Office of 
                National Drug Control Policy Reauthorization Act of 
                2006''; and
                    (C) in clause (iii), by striking ``this paragraph 
                should not remain in effect, this paragraph ceases to 
                be in effect'' and inserting ``subparagraph (B)(iii) 
                should be applied by limiting the total number of 
                patients a practitioner may treat to 30, then the 
                provisions in such subparagraph (B)(iii) permitting 
                more than 30 patients shall not apply, effective''.

SEC. 1103. REPORT ON LAW ENFORCEMENT INTELLIGENCE SHARING.

    Not later than 180 days after the date of enactment of this Act, 
the Director shall submit to Congress a report--
            (1) evaluating existing and planned law enforcement 
        intelligence systems used by Federal, State, local, and tribal 
        law enforcement agencies responsible for drug trafficking and 
        drug production enforcement; and
            (2) addressing--
                    (A) the current law enforcement intelligence 
                systems used by Federal, State, local, and tribal law 
                enforcement agencies;
                    (B) the compatibility of such systems in ensuring 
                access and availability of law enforcement intelligence 
                to Federal, State, local, and tribal law enforcement;
                    (C) the extent to which Federal, State, local, and 
                tribal law enforcement are sharing law enforcement 
                intelligence information to assess current threats and 
                design appropriate enforcement strategies; and
                    (D) the measures needed to ensure and to promote 
                effective information sharing among law enforcement 
                intelligence systems operated by Federal, State, local, 
                and tribal law enforcement agencies responsible for 
                drug trafficking and drug production enforcement.

SEC. 1104. REQUIREMENT FOR SOUTH AMERICAN HEROIN STRATEGY.

    (a) In General.--Not later than 90 days after the date of enactment 
of this Act, the Director, in coordination with the Secretary of State, 
shall submit to Congress a comprehensive strategy that addresses the 
increased threat from South American heroin, and in particular 
Colombian heroin, and the emerging threat from opium poppy grown in 
Peru and often intended for transit to Columbia for processing into 
heroin.
    (b) Contents.--The strategy submitted under subsection (a) shall 
include--
            (1) opium eradication efforts to eliminate the problem at 
        the source to prevent heroin from entering the stream of 
        commerce;
            (2) interdiction and precursor chemical controls;
            (3) demand reduction and treatment;
            (4) alternative development programs, including direct 
        assistance to regional governments to demobilize and provide 
        alternative livelihoods to former members of insurgent or other 
        groups engaged in heroin, cocoa, or other illicit drug 
        production or trafficking;
            (5) efforts to inform and involve local citizens in the 
        programs described in paragraphs (1) through (4), such as 
        through leaflets advertising rewards for information; and
            (6) an assessment of the specific level of funding and 
        resources necessary to simultaneously address the threat from 
        South American heroin and the threat from Colombian and 
        Peruvian coca.
    (c) Treatment of Classified or Law Enforcement Sensitive 
Information.--Any content of the strategy submitted under subsection 
(a) that involves information classified under criteria established by 
an Executive order, or whose public disclosure, as determined by the 
Director or the head of any relevant Federal agency, would be 
detrimental to the law enforcement of national security activities of 
any Federal, foreign, or international agency, shall be presented to 
Congress separately from the rest of the strategy.

SEC. 1105. MODEL ACTS.

    (a) In General.--The Director of the Office of National Drug 
Control Policy shall provide for or shall enter into an agreement with 
a non-profit corporation that is described in section 501(c)(3) of the 
Internal Revenue Code of 1986 and exempt from tax under section 501(a) 
of such Code to--
            (1) advise States on establishing laws and policies to 
        address alcohol and other drug issues, based on the model State 
        drug laws developed by the President's Commission on Model 
        State Drug Laws in 1993; and
            (2) revise such model State drug laws and draft 
        supplementary model State laws to take into consideration 
        changes in the alcohol and drug abuse problems in the State 
        involved.
    (b) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out this subsection $1,500,000 for each of fiscal 
years 2007 through 2011.

SEC. 1106. STUDY ON IATROGENIC ADDICTION ASSOCIATED WITH PRESCRIPTION 
              OPIOID ANALGESIC DRUGS.

    (a) In General.--
            (1) Study.--The Director of the Office of National Drug 
        Control Policy shall request the Institute of Medicine of the 
        National Academy of Sciences to enter into an agreement under 
        which the Institute agrees to study certain aspects of 
        iatrogenic addiction to prescription opioid analgesics included 
        in schedules II and III of the Controlled Substances Act (21 
        U.S.C. 812).
            (2) Iatrogenic addiction.--In this section, the term 
        ``iatrogenic addiction'' means an addiction developed from the 
        use of an opioid analgesic by an individual with no previous 
        history of any addiction, who has lawfully obtained and used 
        the drug for a legitimate medical purpose by administration 
        from, or pursuant to the prescription or order of, an 
        individual practitioner acting in the usual course of 
        professional practice.
    (b) Requirements.--The study conducted pursuant to this section 
shall assess the current scientific literature to determine, if 
possible--
            (1) the rate of iatrogenic addiction associated with the 
        appropriate use of prescription drugs described in subsection 
        (a);
            (2) the impact of iatrogenic addiction associated with the 
        appropriate use of prescription drugs described in subsection 
        (a) on the individual, the prescriber, other patients, and 
        society in general;
            (3) the comparative abuse liability of prescription drugs 
        described in subsection (a) when used properly by the ultimate 
        user for a legitimate medical purpose; and
            (4)(A) what types of prospective or retrospective studies 
        should be undertaken to determine the rate of iatrogenic 
        addiction associated with the appropriate use of the 
        prescription drugs described in subsection (a); and
            (B) a feasible timeline for conducting and reporting such 
        studies, should the current state of the scientific literature 
        be insufficient to determine the rate, impact, and comparative 
        abuse liability of prescription drugs described in subsection 
        (a).
    (c) Report.--Not later than 1 year after the date of enactment of 
this Act, the Director of the Office of National Drug Control Policy 
shall ensure that the agreement under subsection (a) provides for the 
submission of a report to the Congress on the status of the study 
conducted pursuant to this section.

SEC. 1107. REQUIREMENT FOR STRATEGY TO STOP INTERNET ADVERTISING OF 
              PRESCRIPTION MEDICINES WITHOUT A PRESCRIPTION.

    Not later than 120 days after the date of the enactment of this 
Act, the Director of the Office of National Drug Control Policy shall 
submit to Congress a strategy to stop advertisements that provide 
information about obtaining over the Internet drugs (as defined in 
section 702(3) of the Office of National Drug Control Policy 
Reauthorization Act of 1998) for which a prescription is required 
without the use of such a lawful prescription.

SEC. 1108. REQUIREMENT FOR STUDY ON DIVERSION AND INAPPROPRIATE USES OF 
              PRESCRIPTION DRUGS.

    Not later than 90 days after the date of enactment of this Act, the 
Director of the Office of National Drug Control Policy, in consultation 
with the Secretary of Health and Human Services, shall submit to 
Congress a report that includes a plan to conduct a study on the 
illegal diversion and inappropriate uses of prescription drugs, 
including the following:
            (1) Methods to utilize both public use surveys that are in 
        existence as of the date of enactment of this Act and other 
        surveys to provide appropriate baseline data on the natural 
        history of diversion and abuse of prescription drugs that are 
        included in schedules under the Controlled Substances Act to 
        evaluate the extent and nature of potential problems with such 
        use to guide corrective actions which may reduce such problems 
        without unintentionally hindering access to these drugs for 
        legitimate medical purposes. Specifically, other surveys to be 
        considered are those that address the abuse of these substances 
        on a regional or national basis, and those that address the 
        diversion of these substances on a regional or national basis.
            (2) A scientifically based analysis of the relative 
        contribution of both innate and acquired genetic factors, 
        environmental factors, psychological factors, and drug 
        characteristics that contribute to addiction to prescription 
        drugs.

SEC. 1109. REQUIREMENT FOR AFGHAN HEROIN STRATEGY.

    (a) In General.--Not later than 90 days after the date of the 
enactment of this Act, the Director of the Office of National Drug 
Control Policy shall submit to the Congress a comprehensive strategy 
that addresses the increased threat from Afghan heroin.
    (b) Contents.--The strategy shall include--
            (1) opium crop eradication efforts to eliminate the problem 
        at the source to prevent heroin from entering the stream of 
        commerce;
            (2) destruction or other direct elimination of stockpiles 
        of heroin and raw opium, and heroin production and storage 
        facilities;
            (3) interdiction and precursor chemical controls;
            (4) demand reduction and treatment;
            (5) alternative development programs;
            (6) measures to improve cooperation and coordination 
        between Federal Government agencies, and between such agencies, 
        agencies of foreign governments, and international 
        organizations with responsibility for the prevention of heroin 
        production in, or trafficking out of, Afghanistan; and
            (7) an assessment of the specific level of funding and 
        resources necessary significantly to reduce the production and 
        trafficking of heroin.
    (c) Treatment of Classified or Law Enforcement Sensitive 
Information.--Any content of the strategy that involves information 
classified under criteria established by an Executive order, or whose 
public disclosure, as determined by the Director or the head of any 
relevant Federal agency, would be detrimental to the law enforcement or 
national security activities of any Federal, foreign, or international 
agency, shall be presented to Congress separately from the rest of the 
strategy.

SEC. 1110. REQUIREMENT FOR SOUTHWEST BORDER COUNTERNARCOTICS STRATEGY.

    (a) In General.--Not later than 120 days after the date of 
enactment of this Act, and every 2 years thereafter, the Director of 
National Drug Control Policy shall submit to the Congress a Southwest 
Border Counternarcotics Strategy.
    (b) Purposes.--The Southwest Border Counternarcotics Strategy 
shall--
            (1) set forth the Government's strategy for preventing the 
        illegal trafficking of drugs across the international border 
        between the United States and Mexico, including through ports 
        of entry and between ports of entry on that border;
            (2) state the specific roles and responsibilities of the 
        relevant National Drug Control Program agencies (as defined in 
        section 702 of the Office of National Drug Control Policy 
        Reauthorization Act of 1998 (21 U.S.C. 1701)) for implementing 
        that strategy; and
            (3) identify the specific resources required to enable the 
        relevant National Drug Control Program agencies to implement 
        that strategy.
    (c) Specific Content Related to Drug Tunnels Between the United 
States and Mexico.--The Southwest Border Counternarcotics Strategy 
shall include--
            (1) a strategy to end the construction and use of tunnels 
        and subterranean passages that cross the international border 
        between the United States and Mexico for the purpose of illegal 
        trafficking of drugs across such border; and
            (2) recommendations for criminal penalties for persons who 
        construct or use such a tunnel or subterranean passage for such 
        a purpose.
    (d) Consultation With Other Agencies.--The Director shall issue the 
Southwest Border Counternarcotics Strategy in consultation with the 
heads of the relevant National Drug Control Program agencies.
    (e) Limitation.--The Southwest Border Counternarcotics Strategy 
shall not change existing agency authorities or the laws governing 
interagency relationships, but may include recommendations about 
changes to such authorities or laws.
    (f) Report to Congress.--The Director shall provide a copy of the 
Southwest Border Counternarcotics Strategy to the appropriate 
congressional committees (as defined in section 702 of the Office of 
National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 
1701)), and to the Committee on Armed Services and the Committee on 
Homeland Security of the House of Representatives, and the Committee on 
Homeland Security and Governmental Affairs and the Committee on Armed 
Services of the Senate.
    (g) Treatment of Classified or Law Enforcement Sensitive 
Information.--Any content of the Southwest Border Counternarcotics 
Strategy that involves information classified under criteria 
established by an Executive order, or whose public disclosure, as 
determined by the Director or the head of any relevant National Drug 
Control Program agency, would be detrimental to the law enforcement or 
national security activities of any Federal, State, local, or tribal 
agency, shall be presented to Congress separately from the rest of the 
strategy.

SEC. 1111. REQUIREMENT FOR SCIENTIFIC STUDY OF MYCOHERBICIDE IN ILLICIT 
              DRUG CROP ERADICATION.

    (a) Requirement.--Not later than 90 days after the date of 
enactment of this Act, the Director of the Office of National Drug 
Control Policy shall submit to the Congress a report that includes a 
plan to conduct, on an expedited basis, a scientific study of the use 
of mycoherbicide as a means of illicit drug crop elimination by an 
appropriate Government scientific research entity, including a complete 
and thorough scientific peer review. The study shall include an 
evaluation of the likely human health and environmental impacts of 
mycoherbicides derived from fungus naturally existing in the soil.
    (b) Study.--The study required by this section shall be conducted 
in United States territory and not in any foreign country.

SEC. 1112. REQUIREMENT FOR STUDY OF STATE PRECURSOR CHEMICAL CONTROL 
              LAWS.

    (a) Study.--The Director of National Drug Control Policy, in 
consultation with the National Alliance for Model State Drug Laws, 
shall conduct a study of State laws with respect to precursor chemical 
controls.
    (b) Report.--Not later than 6 months after the date of the 
enactment of this Act, the Director of National Drug Control Policy 
shall submit a report to Congress on the results of the study under 
subsection (a), including--
            (1) a comparison of the State laws studied and the 
        effectiveness of each such law; and
            (2) a list of best practices observed with respect to such 
        laws.

SEC. 1113. REQUIREMENT FOR STUDY OF DRUG ENDANGERED CHILDREN PROGRAMS.

    (a) Study.--The Director of National Drug Control Policy shall 
conduct a study of methamphetamine-related activities that are 
conducted by different Drug Endangered Children programs administered 
by States.
    (b) Report.--Not later than 6 months after the date of the 
enactment of this Act, the Director of National Drug Control Policy 
shall submit to Congress a report on the results of the study under 
subsection (a). Such report shall include--
            (1) an analysis of the best practices of the activities 
        studied; and
            (2) recommendations for establishing a national policy to 
        address drug endangered children, based on the Drug Endangered 
        Children programs administered by States.
    (c) Definitions.--In this section--
            (1) the term ``methamphetamine-related activity'' means any 
        activity related to the production, use, or effects of 
        methamphetamine; and
            (2) the term ``drug endangered children'' means children 
        whose physical, mental, or emotional health are at risk because 
        of the production, use, or effects of methamphetamine by 
        another person.

SEC. 1114. STUDY ON DRUG COURT HEARINGS IN NONTRADITIONAL PLACES.

    (a) Finding.--Congress finds that encouraging drug courts and 
schools to enter into partnerships that allow students to see the 
repercussions of drug abuse by non-violent offenders may serve as a 
strong deterrent and promote demand reduction.
    (b) Study.--The Director of the Office of National Drug Control 
Policy shall conduct a study on drug court programs that conduct 
hearings in nontraditional public places, such as schools. At a 
minimum, the study shall evaluate similar programs in operation, such 
as the program operated in the Fourth Judicial District Drug Court, in 
Washington County, Arkansas.
    (c) Requirement.--At the same time the President submits to 
Congress the National Drug Control Strategy due February 1, 2007, 
pursuant to section 706 of the Office of National Drug Control Policy 
Reauthorization Act of 1998, the President shall submit to Congress a 
report on the study conducted under subsection (b). The report shall 
include an evaluation of the results of the study and such 
recommendations as the President considers appropriate.
    (d) Demand Reduction.--In this section, the term ``demand 
reduction'' has the meaning provided in section 702(1) of the Office of 
National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 
1701(1)).

SEC. 1115. REPORT ON TRIBAL GOVERNMENT PARTICIPATION IN HIDTA PROCESS.

    (a) Report Requirement.--The Director of the Office of National 
Drug Control Policy shall prepare a report for Congress on the 
representation of tribal governments in the High Intensity Drug 
Trafficking Areas Program and in high intensity drug trafficking areas 
designated under that Program. The report shall include--
            (1) a list of the tribal governments represented in the 
        Program and a description of the participation by such 
        governments in the Program;
            (2) an explanation of the rationale for the level of 
        representation by such governments; and
            (3) recommendations by the Director for methods for 
        increasing the number of tribal governments represented in the 
        Program.
    (b) Deadline.--The report prepared under subsection (a) shall be 
submitted not later than 1 year after the date of the enactment of this 
Act.
    (c) Definition.--In this section, the term ``High Intensity Drug 
Trafficking Areas Program'' means the program established under section 
707 of the Office of National Drug Control Policy Reauthorization Act 
of 1998 (21 U.S.C. 1706)

SEC. 1116. REPORT ON SCHOOL DRUG TESTING.

    (a) Report Requirement.--The Director of National Drug Control 
Policy shall prepare a report on drug testing in schools. The report 
shall include a list of secondary schools that have initiated drug 
testing from among those schools that have attended conferences on drug 
testing sponsored by the Office of National Drug Control Policy.
    (b) Deadline.--Not later than 120 days after the date of the 
enactment of this Act, the Director of National Drug Control Policy 
shall submit to Congress the report required under subsection (a).

SEC. 1117. REPORT ON ONDCP PERFORMANCE BONUSES.

    (a) Report Requirement.--The Director of National Drug Control 
Policy shall prepare a report on performance bonuses at the Office of 
National Drug Control Policy. The report shall include a list of 
employees who received performance bonuses, and the amount of such 
bonuses, for the period beginning on October 1, 2004, and ending on the 
date of submission of the report.
    (b) Deadline.--Not later than 120 days after the date of the 
enactment of this Act, the Director of National Drug Control Policy 
shall submit to Congress the report required under subsection (a).

SEC. 1118. REQUIREMENT FOR DISCLOSURE OF FEDERAL SPONSORSHIP OF ALL 
              FEDERAL ADVERTISING OR OTHER COMMUNICATION MATERIALS.

    Section 712 is amended to read as follows:

``SEC. 712. REQUIREMENT FOR DISCLOSURE OF FEDERAL SPONSORSHIP OF ALL 
              FEDERAL ADVERTISING OR OTHER COMMUNICATION MATERIALS.

    ``(a) Requirement.--Each advertisement or other communication paid 
for by the Office, either directly or through a contract awarded by the 
Office, shall include a prominent notice informing the target audience 
that the advertisement or other communication is paid for by the 
Office.
    ``(b) Advertisement or Other Communication.--In this section, the 
term `advertisement or other communication' includes--
            ``(1) an advertisement disseminated in any form, including 
        print or by any electronic means; and
            ``(2) a communication by an individual in any form, 
        including speech, print, or by any electronic means.''.

SEC. 1119. AWARDS FOR DEMONSTRATION PROGRAMS BY LOCAL PARTNERSHIPS TO 
              COERCE ABSTINENCE IN CHRONIC HARD-DRUG USERS UNDER 
              COMMUNITY SUPERVISION THROUGH THE USE OF DRUG TESTING AND 
              SANCTIONS.

    At the end of the Act, insert the following:

``SEC. 716. AWARDS FOR DEMONSTRATION PROGRAMS BY LOCAL PARTNERSHIPS TO 
              COERCE ABSTINENCE IN CHRONIC HARD-DRUG USERS UNDER 
              COMMUNITY SUPERVISION THROUGH THE USE OF DRUG TESTING AND 
              SANCTIONS.

    ``(a) Awards Required.--The Director shall make competitive awards 
to fund demonstration programs by eligible partnerships for the purpose 
of reducing the use of illicit drugs by chronic hard-drug users living 
in the community while under the supervision of the criminal justice 
system.
    ``(b) Use of Award Amounts.--Award amounts received under this 
section shall be used--
            ``(1) to support the efforts of the agencies, 
        organizations, and researchers included in the eligible 
        partnership;
            ``(2) to develop and field a drug testing and graduated 
        sanctions program for chronic hard-drug users living in the 
        community under criminal justice supervision; and
            ``(3) to assist individuals described in subsection (a) by 
        strengthening rehabilitation efforts through such means as job 
        training, drug treatment, or other services.
    ``(c) Eligible Partnership Defined.--In this section, the term 
`eligible partnership' means a working group whose application to the 
Director--
            ``(1) identifies the roles played, and certifies the 
        involvement of, two or more agencies or organizations, which 
        may include--
                    ``(A) State, local, or tribal agencies (such as 
                those carrying out police, probation, prosecution, 
                courts, corrections, parole, or treatment functions);
                    ``(B) Federal agencies (such as the Drug 
                Enforcement Agency, the Bureau of Alcohol, Tobacco, 
                Firearms, and Explosives, and United States Attorney 
                offices); and
                    ``(C) community-based organizations;
            ``(2) includes a qualified researcher;
            ``(3) includes a plan for using judicial or other criminal 
        justice authority to administer drug tests to individuals 
        described in subsection (a) at least twice a week, and to 
        swiftly and certainly impose a known set of graduated sanctions 
        for non-compliance with community-release provisions relating 
        to drug abstinence (whether imposed as a pre-trial, probation, 
        or parole condition or otherwise);
            ``(4) includes a strategy for responding to a range of 
        substance use and abuse problems and a range of criminal 
        histories;
            ``(5) includes a plan for integrating data infrastructure 
        among the agencies and organizations included in the eligible 
        partnership to enable seamless, real-time tracking of 
        individuals described in subsection (a);
            ``(6) includes a plan to monitor and measure the progress 
        toward reducing the percentage of the population of individuals 
        described in subsection (a) who, upon being summoned for a drug 
        test, either fail to show up or who test positive for drugs.
    ``(d) Reports to Congress.--
            ``(1) Interim report.--Not later than June 1, 2009, the 
        Director shall submit to Congress a report that identifies the 
        best practices in reducing the use of illicit drugs by chronic 
        hard-drug users, including the best practices identified 
        through the activities funded under this section.
            ``(2) Final report.--Not later than June 1, 2010, the 
        Director shall submit to Congress a report on the demonstration 
        programs funded under this section, including on the matters 
        specified in paragraph (1).
    ``(e) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out this section $4,900,000 for each of fiscal 
years 2007 through 2009.''.

SEC. 1120. POLICY RELATING TO SYRINGE EXCHANGE PROGRAMS.

    Section 703(a) (21 U.S.C. 1702(a)) is amended by adding at the end 
the following:
``When developing the national drug control policy, any policy of the 
Director relating to syringe exchange programs for intravenous drug 
users shall be based on the best available medical and scientific 
evidence regarding their effectiveness in promoting individual health 
and preventing the spread of infectious disease, and their impact on 
drug addiction and use. In making any policy relating to syringe 
exchange programs, the Director shall consult with the National 
Institutes of Health and the National Academy of Sciences.''.

            Passed the House of Representatives December 7, 2006.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.